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Abstract
This thesis explores magnetic resonance (MR) imaging methodologies that provide
in vivo spectroscopic information. To date such information has not been routinely acquired
and used in diagnosis. The general objective of the thesis is to develop and implement new
and fast MR spectroscopic imaging techniques that can be practically utilized to study
spectroscopic information in vivo.
This thesis presents innovative line scan spectroscopic imaging methodologies
based on spectroscopic interrogation of voxels along strategically oriented tissue columns.
The techniques combine some of the most attractive features of both imaging and
spectroscopic methods utilizing Carr-Purcell-Meiboom-Gill multiple-echo sequences, rapid
acquisition and relaxation enhanced or equivalently fast spin echo sequences, inner-volume
localization, and chemical shift imaging principles. The techniques offer a compromise
between the low-spectral-resolution, high-spatial-resolution, large-volume-coverage
imaging methods of Dixon and Sepponen and the high-spectral-resolution, single-voxel
localized proton spectroscopic approaches. Developed and implemented on the conventional
1.5 Tesla clinical MR imaging scanner with standard software and hardware configurations,
the non-invasive line scan spectroscopic imaging techniques generate spectroscopic images
with high spatial, variable spectral resolution and adequate volume coverage in clinically
useful time periods of 10 minutes or less.
This thesis demonstrates the line scan spectroscopic imaging techniques in vivo.
Spectral concentrations and relaxation times are obtained for bone marrow and brain
metabolites. Specifically, quantification of water and saturated fat (concentration and T2
relaxation time) is performed on vertebral bone marrow in a group of healthy adult
volunteers. Studies of developing bone marrow in knee are performed on a group of
children and a group of adult volunteers. Furthermore, with variable spectral resolution and
slightly modification, the techniques are shown applicable for quantification the lipid
chemical composition. The applications include measurements of lipid spectral T1
relaxation time, detection of terminal methyl protons even with a limited spectral resolution,
monitoring of degree of unsaturated fatty acid. In addition, the techniques are modified and
applied to quantify and map human brain metabolites. The clinical feasibility of brain
metabolite studies is illustrated in a group of healthy adult volunteers and a tumor patient.
The techniques developed in this thesis promise many possible applications. One is
to quantitatively study lipid spectra in bone marrow during and after radiation therapy and
chemotherapy for patients with bone marrow diseases like leukemia. Another one is to
study the evolution of cerebral metabolites within brain tumors to see how relative
concentrations of MR observable metabolites correlate with the state of the tumors and the
relative progress of various therapies. The other application is to study lipid metabolic
disorders, such as cystic fibrosis. The techniques also provides the opportunities to perform
dynamic chemical shift imaging studies in vivo.
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2.1 Block diagram of the hardware configurations of the 1.5 T clinical MRI GE Signa
scanner used for experiments in this thesis. The hardware consists of the host computer,
transceiver processing and storage chassis and consolidated pulse control module.
. . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.2 Schematic representation of RF receiver of the scanner which include mixers, the
anti-alias filter, A/D converters, and digital filtering.
. . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.1 The target localization sequence for generating a scout image with column
localization. It is a RARE type sequence with a saturation pulse added prior to the
excitation. The SAT pulse saturates spins from selected tissue column so that the column
appears as a dark band in the section image.
. . . . . . . . . . . . . . . . . . . . . . . . . 4 5
3.2 Line scan CPMG spectroscopic imaging sequence. Echoes are collected without
readout gradient. In each excitation, same phase encoding gradient is used for all echoes.
Up to 8 echoes can be collected even though only three echoes are shown in the figure.
. . . . . . . . . . . . . . . . . . . . . . . . 47
3.3 Schematic representation of the column generated by interaction of 90 slice-
selective plane and 180 refocusing plane. The spatial dimension (along the column) is
phase encoded. The spectra (perpendicular to the column) are acquired without the read
gradients.
. . . . . . . . . . . . . . . . . . . 4 8
3.4 k-space representation of signal acquisition with CPMG. Each k-line corresponds
an excitation with distinct phase encodes. The who k-space is sampled sequentially. The
solid line is the first phase encode step, and the dashed lines (top to bottom) correspond the
second, the third, ..., phase encodes.
. . . . . . . . . . . . . . . . . . . . . . . . 52
3.5 Line scan RARE spectroscopic imaging sequence. The 900 pulse along with
selective gradient excites a plane that is orthogonal to the plane refocused by 180 ° pulses.
Each echo is individually phase encoded before echo sampling and "unwound" after the
sampling. The echoes are acquired without readout gradients. Only 3 echoes are shown.
. . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.6 Scheme of phase encode from - Kmax to Kmax . The vertical axis represents the
relative T2 weighting at each phase encode step. (a): Zero phase occurs midway through
the sampling cycle. (b): Circularly rotating the zero phase forward in time. (c): Shuffling
the phase encodes between odd and even echoes. (d): Two-shot RARE method for phase
encoding.
. .. . . . . . . . . . . . . . . . . . . . . . . . 55
3.7 Flow chart of automated program for imaging post-processing. The functions of
the program are to read in spectroscopic images, extract spectra from each voxel of the
spectroscopic images, fit with Gaussian functions, calculate the peak areas, fit with
exponential decay function, and output results.
. . . . . . . . . . . . . . . . . . . . . . . . . 58
4.1 Fat percentage measurement of a phantom with different mixtures of agar and
mayonnaise. Horizontal axis is calculated by weighted and vertical axis is measured by line
scan MR method. The solid line is the best linear fit.
. . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.2 (a): Sgittal slice of 31-year-old man. The image contains a large portion of the
lumbar spine. (b): Sagittal scout image with a dark band representing the target column. The
5 x 5 mm 2 column extends along the lumber spine. (c): First echo spectroscopic image of
this column at TE of 48 ms. The horizontal axis is spectroscopic dimension and vertical
axis is spatial dimension. The water peak is to the left of the saturated fat proton peak. The
bright water intensities at spatial locations corresponding to the intervertebral disks and the
lack of any lipid line in these regions, while spatial locations corresponding to vertebral
marrow contain both water and lipid signal. (d): Second echo spectroscopic image of the
column at TE of 96 ms.
. . . . . . . . . . . . . . . . . . . . . . . . 70
4.3 Spectra extracted from one location in the vertebral marrow of the 31-year-old man
(shown at Figure 4.2) at echo times of 48, 96, 144, and 192 ms. The signal-to-noise ratios
calculated from the maximum amplitude of water-peak over baseline were on the order of
100 for the first echo spectra. The solid lines through the experimental spectral points are
theoretical fits to Gaussian functions.
. . . . . . . . . . . . . . . . . . . . . . . . . . 7 2
4.4 T2 decay curve of saturated-fat and water protons calculated from peak area
quantification at different TEs. Also shown are least square fits of the data to
monoexponential function.
. . . . . . . . . . . . . . . . . . . . . . . . . . 73
4.5 Plot of spectral T2 relaxation times versus position (superior to inferior) along the
spinal column for a 37-year-old man. At intervertebral disk locations, only the water peak
was analyzed and only water T2 values in these regions are shown. A total of 39 voxels
within bone marrow contributed to this data set.
. . . . . . . . . . . . . . . . . . . . . . . . . 75
4.6 (a): Sagittal scout image of the knee of a 57-year-old man. The selected tissue
column appears as a dark band on the slice image. The arrow points a location within the
proximal tibial metaphysis region where the spectra are extracted and fitted on the
following. (b): First echo spectroscopic image with TE of 78 ms. The echo readout is 64
ms. The horizontal axis is the spectral dimension and vertical axis is spatial dimension. (c,
d): are the first and second spectroscopic image respectively with echo readout of 32 ms.
The TE is 48 ms for the first echo and 96 ms for the second. Because of the shorter echo
readout in (c) and (d), the spectral resolution is reduced compared with that in (b).
. . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.7 Spectra extracted and best exponential fit of the first echo (a) and second echo (b)
spectroscopic images from metaphyseal marrow at the arrows location in Figure 4.6. The
spectral readouts are 32 ms and the TEs for (a) and (b) are 48 and 96 ms respectively. The
circles are experimental data and solid line is the best exponential fit. The proton peak
assignments are: olefinic proton (-CH2 - CH = CH -CH 2 -) at 5.4 ppm, water proton at
4.7 ppm, unresolved methylene (-CH2-) n and methyl protons (-CH3) at 1.2 ppm, and
alpha protons (- CH 2- CH =, = CH - CH 2- CH =) at 2.4 ppm.
. . . . . . . . . . . . . . . . . . . . . . . . . . 8 1
4.8 (a): Sagittal scout image of the knee of a 2-year-old girl with a dark band
representing the selected tissue column. The girl was the youngest among the volunteers.
(b, c, d): The first , second and fifth echo spectroscopic images of the column. The TEs are
48, 96 and 240 ms respectively. The marrow water peak obscures the olefinic proton peak
in both metaphyses and persists even in the later echoes (d). This allows for a full 8-echo
analyses of the T2 decay curves for both the water and methylene/methyl peaks throughout
most of the marrow sampled.
. . . . . . . . . . . . . . . . . . . . . . . . . . 83
4.9 Single voxel spectra extracted from the distal femoral epiphysis of the 2-year-old
girl (shown in Figure 4.8). The spectral readout was 32 ms with TE of 48 ms.
. . . . . . . . . . . . . . . . . . . . . . . . . 82
4.10 Spectra extracted from single voxels from a 32-year-old woman (top) and a 13-
year-old boy (bottom). Single voxels are located at regions of DFM, DFE, PTE, PTM.
Spectral peaks are identified with arrows.
. . . .. . . . . . . . . . . . . . . . . . . . . 86
4.11 Gaussian fits to the alpha and methylene/methyl region (top) and olefinic/water
region (bottom). The spectra were extracted from adult metaphyseal marrow of a 32-year-
old woman at the first three echoes (TE: 48, 96, 144 ms).
. . . . . . . . . . . . . . . . . . . . . . . . 87
4.12 (a): Peak area decay with TE as averaged over 10 voxels in the metaphysis of a 38-
year-old man for olefinic protons (squares), water protons (triangles), and alpha protons
(diamonds). The solid line is the least squares fits of the data with a mono-exponential
decay function. (b): Methylene/methyl peak area decay from metaphyseal marrow in the
38-year-old man (diamonds) and in a 13-year-old boy (squares). The water peak area
decay from the boy is also plotted (triangles) and, unlike the adult yellow marrow water
peak (triangle in (a)), is quantifiable for seven echoes and has a substantial amplitude when
extrapolated to TE = 0.
. . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.13 Quantitative analyses of water and methylene/methyl peaks of the 2-year-old girl in
Figure 4.8. (a): Plot of methylene/methyl (solid line) and water (dashed line) extrapolated
peak areas as a function of pixel position along the column. The pixels are 1.6 mm apart.
(b): T2 map for methylene/methyl peak (solid line) and water peak (dashed line) along the
column.
.. . . . . . . . . . . . . . . . . . . . . . . . . 9 1
4.14 (a): Histograms of extrapolated peak areas in the adult population as found in the
distal femoral metaphysis (top) and the distal femoral epiphysis (bottom). For each subject,
olefinic proton (open bars), water proton ( filled bars), alpha proton (left diagonal) and
methylene/methyl proton ( right diagonal) peak areas are plotted. (b): Histograms of
extrapolated peak areas in the children from the same anatomic regions (DFM and DFE).
. .. . . . . . . . . . . . . . . . . . . . . . . . 9 3
4.15 (a): Sagittal slice of the knee of a 27-year-old woman in adult volunteers. This
woman showed abnormally high water content in the distal femoral metaphysis, most
probably due to residual hematopietic marrow. (b, c, d): The first echo spectroscopic
images with a spectral readout of 32, 64 and 96 ms respectively, which correspond the
spectral resolution of 16, 8 and 5 Hz respectively.
. . . . . . . . . . . . . . . . . . . . . . . . . . 9 5
5.1 Structure of chemically distinct lipid protons of triacylglycerols.
. . . . . . . . . . . . . . . . . . . . . . . . . 107
5.2 (a): Scout image of an array of oil phantoms with a selected tissue column. The
mixtures for each vial are (from top to bottom): 100% fish oil; 75% fish oil and 25%
mineral oil (by weight); 50% fish oil and 50% mineral oil; 25% fish oil and 75% mineral
oil; 100% mineral oil. The vertical dark band represents the targeted column. (b): The first
echo CPMG spectroscopic image with TE of 78 ms. The horizontal dimension is spectral
axis and the vertical is spatial axis. The number of distinguishable resonance peaks
decreases from top to bottom vial. This is consistent with the fact that fish oil has higher
degree of unsaturation than mineral oil since the double bond yields more resonance peaks
than the saturated single bond. The arrow points where fishoil spectra are to be extracted.
(c): The second echo CPMG spectroscopic image with TE of 156 ms. (d): 3-echo-train
RARE spectroscopic image with effective TE of 156 ms.
. . . . . . . . . . . . . . . . . . . . . . . . . 110
5.3 The first and second echo spectra extracted from the voxel where the arrow points
at in Figure 5.2. Peak #1 is assigned as the olefinic proton (-CH=CH-) at 5.6 ppm, peak #4
is the proton in between the double bonds (=C- CH2 -C=) at 2.8 ppm, peak #5 is the proton
that a to carboxyl (O=C- CH 2 -) at 2.2 ppm, peak #6 is the proton that a to double bond (-
C=C- CH 2 -) at 1.9 ppm, peak #7 is methylene proton (-CH2 -) n at 1.2 ppm, peak #8 is
terminal methyl (-CH3 ) at 0.9 ppm, peak #9 is the proton second next to carboxyl (O=C-
CH 2 -CH 2 -) at 1.5 ppm.
. . . . . . . . . . . . . . . . . . . . . . . . 112
5.4 Methylene and olefinic proton intensity (peak area) in bone marrow of a 55-year-old
healthy man versus inversion time. (a) is inversion recovery T1 relaxation curve for
methylene protons and (b) is olefinic proton. The error bars come from averaging of a few
voxels in bone marrow along the tissue column. The solid lines represent a best non-linear
fit of the form: y = M1 - M2 exp(-x / T1), where M 1 stands for the initial magnetization
after the inversion pulse. The fitted T1 (mean ± SD) is 288 ±7 ms for methylene proton
and 460 + 98 ms for olefinic proton.
. . . . . . . . . . . . . . . . . . . . . . . . 115
5.5 In vivo marrow spectra acquired at TI values of 160 to 200 ms from the 55-year-old
man (Figure 5.4). The persistent signal at 0.9 ppm as the large methylene peak passes
through a null is attributed to terminal methyl protons with unspecified, but longer, T1
values as compared to methylene protons. From TI of 160 ms to 180 ms, the methylene
peak is nulled gradually. At TI of 180 ms, the inversion pulse nulls the methylene peak
almost completely and the methyl peak becomes observable.
. . . . . . . . . . . . . . . . . . . . . . . . . . 117
5.6 (a): Sagittal scout image of the knee from this healthy 55-year-old man. The selected
column appears as a dark horizontal band. (b): 3-echo RARE spectroscopic image from the
column with a non-selective inversion pulse. The inversion time was 190 ms. The other
scan parameters are: 2 s TR; 48 ms echo spacing; 96 ms effective TE; 30 cm; 128 phase
encoding steps; 1 NEX. (c, d) are the first and second echo CPMG spectroscopic images
with TE of 48 ms and 96 ms respectively. The arrow points where the spectra are to be
extracted. As inversion pulse nulls the methylene peak, the small terminal methyl peak is
visible even for 32 ms echo readouts.
. . . . . .. . . . . . . . . . . . . . . . . . 1 19
5.7 Spectra of the first four echoes extracted from the arrow location in Figure 5.6 (c).
The TEs are 48, 96, 144, and 192 ms for four echoes respectively. The spectra are extracted
and averaged over neighboring 4 pixels to increase the signal-to-noise ratio.
. . . . . . . . . . . . . . . . . . . . . . . . . . 12 1
6.1 A spectroscopic image of a column across the brain from left to right without the
water suppression and lipid saturation. The huge water signal and lipid signal make the
observation of low concentration brain metabolites impossible.
. . . . . . . . . . . . . . . . . . . . . . . . . . 133
6.2 Line scan CPMG spectroscopic imaging sequence modified for brain metabolites
measurement. A non-selective 180 pulse nulls the skull lipid signal at properly chosen TI.
Three CHESS pulses suppress the water signal. Echoes are corrected without readout
gradients. The figure shows only 2 echoes.
. . . . . . . . . . . . . . . . . . . . . . . . . 134
6.3 Column localization procedures and multi-echo line scan mapping of brain
metabolites in a healthy 38-year-old man. (a): One of five localizing images acquired in 23
seconds with a 3 echo RARE sequence using TR of 600 ms and an effective TE of 12 ms.
This image depicts the 15 mm thick column location. The tissue column was chosen
oriented from left to right through ventricular spaces. (b): A 4 seconds scout image (5 echo
RARE, 30 phase encodes, TR of 600 ms) used to quickly outline and confirm the position
of the target tissue column with a dark saturation band. The very bright signal from
unsaturated tissue is a consequence of the muliplicative factor of 350 applied to the
sampled data for bringing up the low concentration metabolites. (c - e): First 3 of 5-echo
CPMG spectroscopic images of the column with signal readout setting of 128 ms. The
echo times are 145, 290, 435 ms respectively. These images were acquired in 8 minutes
and 42 seconds (8 signal averages, 30 phase encodes, 2 s TR). The absolute spectral
resolution (vertical axis) is 8 Hz which is zero filled to 4 Hz. The nominal voxel size is
1.5 x 1.5 x 1 cm 3 , or 2.25 cc and zero filling making an apparent spatial resolution of
approximately 1.2 mm along the column. The arrows point the residual water resonance,
the lipid resonance from the skull, the NAA, and the combined Cho+Cr resonance. (f): A
90 seconds 3-echo RARE spectroscopic image of the column. The effective TE is 290 ms
with echo readouts of 128 ms. Primary bands from brain metabolites are still detectable,
though considerable spatial blurring due to the T2 weighting of k-space data is observed.
Note that despite the spatial blurring of lipid signal along the column, the lipid signal never
intersects with the NAA band anywhere in the brain. (g): A summation image from the
first 3 echoes. It was generated by adding raw data of the first 3 echoes before Fourier
transformation and magnitude reconstruction. The T2 weighting of such image is given by
TE and n, as defined in the previous section. Signal-to-noise ratio measured for NAA is an
approximately 15% better than that from the first echo spectra in (c).
. . . . . . . . . . . . . . . . . . . . . . . . . . 136
6.4 Spectra of the first 3 echoes of the CPMG acquisition extracted from the arrow
location in Figure 6.3 (g). The nominal voxel size is 15 x 15 x 5 mm3 . The solid lines are
the best fits to Gaussian functions for the residual water peak, the overlapping Cho+Cr
peak, and the NAA peak.
. . . . . . . . . . . . . . . . . . .. 139
6.5 Spectral T2 decay of the combined Cho+Cr peak area and the NAA peak area with
echo time from the volunteer study in Figure 6.3. The plot was generated by averaging data
from four 15 x 15 x 5 mm 3 voxels along the column. T2 relaxation times estimated are:
318 ms (combined Cho+Cr) and 357 ms (NAA).
. . . . . . . . . . . . . . . . . . . . . . . . . . 140
6.6 Spatial profile for water and NAA peaks along the column. The integrated water
and NAA signal intensities as functions of position along the column are plotted. The water
trace was taken directly from integration of signal intensity across the column dimension in
the T1-weighted image (Figure 6.3 (a)). The locations corresponding to the ventricles
appear as dips in the water profile due to the T1-weighting nature of this localizing image
(TR/TE = 600/12 ms). The NAA trace was taken from integration across the NAA
frequency band in the first echo spectroscopic data sets of the column (TE = 145 ms,
Figure 6.3 (c)). The metabolites trace has been multiplied by a scaling factor to make it
comparable to the water trace for visualization. Both traces show coincident spikes at the
edges of the skull due to strong lipid signal in the T1 -weighted localizer and to lipid signal
bleed along the frequency direction into the NAA band at scalp locations in the TE = 145
ms spectroscopic image.
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6.7 line scan metabolite mapping of a healthy 26-year-old man with a 20 x 20 mm2 )
column oriented anteriorly to posteriorly. (a): A localizing image acquired in 23 seconds
with a 3 echo RARE sequence (TR/TE = 600/12). (b): A 15 second scout image (5 echo
RARE, 120 phase encodes, TR = 600 ms) used to confirm the position of the target tissue
column with a dark saturation band. Unlike Figure 6.3 (b), the multiplicative factor of 350
has not been applied to the sampled data, allowing one to see some anatomy. (c): The first
echo CPMG spectroscopic image. In this case, 114 ms TE, 96 ms echo readouts and 5
echoes CPMG were employed. The smaller echo spacing reduces T2-weighted signal loss
and leads to a higher temporal sampling of spectral T 2 decay at the expense of spectral
resolution. The effective spectral resolution is 10.4 Hz for such scan. Note that the
metabolites mapping along the column, the NAA and the combined Cho+CR, are curved
in the image. The curvature means a shift in resonance frequency, which is caused by
magnetic field inhomogeneity and magnetic susceptibility effect. (d): The summation
spectroscopic image generated by adding data from the first 3 echoes (114, 228, and 342
ms) of the CPMG acquisition.
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6.8 An example of the techniques as applied to a 17-year-old boy with a brain tumor of
glial origin. Shown are the 20 x 20 mm2 tissue column selected for interrogation from a
T2 -weighted localizing image (a), the summation image generated from the first 3 echoes
of a 5-echo CPMG data set (b), and the 3 echo RARE spectroscopic image acquired only
in 90 seconds (c). The scan parameters are identical to those used for Figure 6.3. The
location of the tumor, marked with an arrow in Figure 6.8 (b), clearly shows a depletion of
NAA signal and an increase in the combined Cho+Cr peak, presumably due to increased
choline in tumor cells. Note that with this spectral resolution, Gibbs artifact from the lipid
signals in the scalp do not wander into the NAA frequency band despite inhomogeneity
induced "bowing" signal along the column.
. . . .. . . . . . . . . . . . . . . . . . . . 147
6.9 (a, b): spectra at each echo time extracted from locations in the tumor and from
normal brain tissue on the contralateral side for the patient in Figure 6.8. The nominal voxel
size is 20 x 20 x 5 mm 3. The T2 value of the composite Cho+Cr peak in the tumor,
averaged from two locations, was 303 ± 37 ms. The Cho+Cr T2 value for normal brain
tissue, averaged from four separate 20 x 20 x 5 mm 3 voxels located on the contralatereal
side was 385 ± 45 ms.
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6.10 Spatial profiles for combined Cho+Cr, NAA, and water signals for the tumor
patient in Figure 6.8. The metabolites signals are integrated across the column from the
summation image of Figure 6.8 (b), and the water profile extracted from T2-weighted
localizer of Figure 6.8 (a). The vertical scaling of the metabolites was performed to allow a
comparison with the water profile. Horizontal scaling was also performed to account for
the different FOV for the localizing image and spectroscopic image. The sharp lipid peak
provide a natural reference points for checking the horizontal scaling factor.
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Chapter 1
Introduction
In this thesis innovative magnetic resonance (MR) spectroscopic imaging techniques
and their applications are demonstrated. The general objective of the thesis is to develop and
implement new and fast MR methodologies to study spectroscopic information in vivo. The
purpose of this chapter is to review MR spectroscopic imaging and the problems that
prevent its practical use clinically, to present an outline on approaches of the thesis, and also
to highlight the main contributions of this thesis to the field of MR spectroscopic imaging.
This chapter is organized as follows. In Section 1.1 a review on spectroscopic imaging
techniques and their associated problems are presented. In Section 1.2 an overview of this
thesis is stated. In section 1.3 the factors that motivated the thesis are discussed. Then the
main contributions of the thesis are highlighted in Section 1.4. This is followed by an
outline of the thesis in Section 1.5.
1.1 Review of Spectroscopic Imaging
Proton MR imaging (MRI) is widely used as a diagnostic modality. Images of
internal organs in the human body are routinely acquired by MRI scans. These MR images
are collective contributions from chemically distinct hydrogen nucleus within voxels. The
images usually reflect water content and in some cases and to some degree, they represent
lipid protons. The intensity of the images depend on average relaxation times and density
contributions from chemically distinct proton species. Therefore, the diagnosis with MR
images alone often lacks biochemical specificity. It is well known that MR can be used to
detect hydrogen nuclei associated with molecules other than water. The basis is that these
hydrogen nuclei precess at slightly different frequencies within the magnet. The frequency
shift, termed as chemical shift, is determined by the molecular structure and chemical
environment. Identifying the types and quantities of different hydrogen nuclei through their
chemical shift with MR spectroscopy will give not only biological but also molecular and
chemical environmental information. This qualitative and quantitative information may play
an important clinical diagnostic role complimentary to conventional MR imaging. MR
spectroscopy can provide a non-invasive in vivo approach for biochemical analysis in
humans [1, 2]. One of the potential applications may be in monitoring and assessment of
the therapeutic interventions. The spectroscopic information may provide further insight into
both radiation therapy follow-up assessment and prognosis if it could show changes at the
cellular biochemical level that precede the morphologic changes detected with MR imaging
and/or other radiological imaging modalities. Because of the demands on hardware and
methodology, as well as the lack of clearly defined clinical usage, spectroscopic information
has not been acquired and used clinically, and so presents a challenge to both scientists and
manufacturers in proving its clinical applicability [3].
There are many ways to study spectroscopic information. The general approaches
are through imaging based methods, spectroscopy methods, or spectroscopic imaging
methods.
The image approach to extract chemical shift was proposed by Dixon and
independently by Sepponen [4, 5]. The technique needs two acquisitions to separate water
and saturated fat (methylene), the two dominate peaks in proton spectra of many tissues.
One acquisition is an "in phase" image, whose phase difference of water and fat is zero,
another is "opposed phase" image, whose phase difference is 180 degrees. The "water-
only" and "fat-only" images can be obtained by addition and subtraction of in phase and
opposed phase images. This two-point technique and its modified version, multi-point
Dixon technique [6], have been used for composition assessment in hematological bone
marrow disorders [7], Gaucher disease [8], acute leukemia [9] and to study effects of
radiation therapy and chemotherapy [10-13]. Such imaging based approaches generate
images with high spatial resolution, excellent anatomic details and contrast to noise ratio, but
poor spectral resolution. Since there are more resonance peaks other than water and
saturated fat (methylene) in each voxel [14], the limitations of a few points image
approaches become obvious in some applications.
There are several spectroscopic approaches to study chemical shift information, such
as Stimulated Echo Acquisition Mode (STEAM) sequences [15-18] and the Point Resolved
Spatial Selection (PRESS) sequence [P.A. Bottomley, U. S. Patent 4480 228 (1984), 6].
These volume-localized spectroscopy techniques have been used to acquire spectra from
single voxels in brain [19] and in vertebral bone marrow [20-22]. Such approaches offer
high spectral resolution and can provide more precise measurements of water and fat
(methylene/methyl) cellularity than Dixon-based imaging methods. In addition to water and
methylene/methyl peak quantification, smaller lipid resonance peaks other than water and
methylene peaks as well as spectral peak relaxation times can also be measured. These offer
a means to assess lipid chemical composition and to probe microscopic chemical and
physical environments of protons under observation [23-24]. The single voxel spectroscopy
approaches are limited by relatively low spatial resolution and volume coverage. Lengthy
acquisition times are required if relaxation behavior is to be studied.
1.2 Thesis Overview
In this thesis, the author presents line scan spectroscopic imaging methods based on
spectroscopic interrogation of voxels along strategically oriented tissue columns [25-26].
The techniques combine some of the most attractive features of both imaging and
spectroscopic methods utilizing Carr-Purcell-Meiboom-Gill (CPMG) multiple-echo
sequences [27], rapid acquisition and relaxation enhanced (RARE) or equivalently fast spin
echo (FSE) sequences [28-30], inner-volume localization [28, 31], and chemical shift
imaging principles [29, 32]. The techniques offer a compromise between the low-spectral-
resolution, high-spatial-resolution, large-volume-coverage imaging methods of Dixon and
Sepponen and the high-spectral-resolution, single-voxel localized proton spectroscopic
approaches. Developed and implemented on the conventional 1.5 Tesla clinical MR imaging
scanner with standard software and hardware configurations, the non-invasive line scan
spectroscopic imaging techniques generate spectroscopic images with high spatial, variable
spectral resolution and adequate volume coverage in clinically useful time periods of 10
minutes or less.
In this thesis, the line scan spectroscopic imaging techniques are demonstrated in
vivo [33-38]. Spectral concentrations and relaxation times are obtained for bone marrow and
brain metabolites. Specifically, quantification of water and saturated fat, or cellularity
measurement, is performed on vertebral bone marrow in a group of healthy adult
volunteers. Studies of developing bone marrow in knee are performed on a group of
children and a group of adult volunteers. Furthermore, with variable spectral resolution and
slight modification, the techniques are shown applicable for quantification the lipid chemical
composition [33-36]. The demonstrations include measurements of lipid spectral T1
relaxation time, detection of terminal methyl protons even with a limited spectral resolution
[33], monitoring of degree of unsaturated fatty acid, and study of levels of mono-
unsaturated versus poly-unsaturated triglycerides [34]. In addition, the techniques are
modified and applied to quantify and map human brain metabolites. The clinical feasibility
of brain metabolite studies is illustrated in a group of healthy adult volunteers and a tumor
patient.
The techniques developed in this thesis promise many possible applications. One is
to quantitatively study lipid spectra in bone marrow during and after radiation therapy and
chemotherapy for patients with bone marrow diseases like leukemia. Another one is to
study the evolution of cerebral metabolites within brain tumors to see how relative
concentrations of MR observable metabolites correlate with the state of the tumors and the
relative progress of various therapies. The other application is to study lipid metabolic
dtisorders, such as cystic fibrosis.
The specific goals of this thesis are: (1). to demonstrate the techniques as a very
applicable tool in the clinical setting; (2). to apply the techniques to the studies of vertebral
bone marrow in the lumber spine of adults; (3). to apply the techniques to the
characterization of developing bone marrow in the knees of children and adults; (4). to
nmodify and apply the techniques to the studies of human brain metabolites; (5). to
determine optimal compromises between acquisition speed, spectral resolution, and
relaxation measurement; (6). to automate the image processing algorithms for fast data
analysis and clinical interface and/or interpretation.
1.3 Motivation of the Thesis
The first motivation factor for this thesis is to develop and optimize new MR
methodologies to generate spectroscopic images. For in vivo studies the methods are
designed to combine the imaging methods with spectroscopy. They are optimized to
maintain a balance between spectral resolution, volume coverage, speed and relaxation
properties. To utilize spectroscopic information practically and effectively in clinical setting,
the new methods have to be fast enough and convenient enough so that they can be easily
incorporated into clinical protocols. At the same time, the methods have to provide well-
defined spectroscopic information.
The second motivation factor is to see the new MR spectroscopic imaging tools
successfully implemented on a conventional MRI scanner. The spectroscopic imaging can
then be tested for their use in clinical diagnosis. To bring the broad spectrum of
spectroscopic information into clinical reality, new tools that ensure spectroscopic
information can be acquired accurately and practically are needed. The impact can be huge
with appropriate methodologies developed and implemented on conventional 1.5 T clinical
scanner without costly hardware upgrades.
A final compelling motivation factor is to develop new spectroscopic imaging
methodologies that offer opportunities for dynamic chemical shift imaging study in vivo. As
in functional MR imaging, the scan time or temporal resolution is crucial in dynamic
studies. Developing fast MR spectroscopic imaging methods may provide such
possibilities.
1.4 Main Contributions of the Thesis
In this section the significant contributions of this thesis to the field of MR
spectroscopic imaging are highlighted as follows:
The major contribution of the thesis is the development and implementation of
innovative MR spectroscopic imaging methodologies [25, 26, 33-39]. Specifically, the
focus is on combining CPMG, RARE (or FSE) imaging techniques, inner volume
selection scheme, with principles of spectroscopy. The methods offer a compromise
between the low-spectral-resolution, high-spatial-resolution, large-volume-coverage
imaging methods of Dixon and Sepponen and the high-spectral-resolution, single-voxel
localized proton spectroscopic approaches. The acquisitions can be either in imaging fashion
that generates the localizing images or in spectroscopic imaging fashion that generates
spectroscopic images with CPMG and RARE techniques. Extensive regions of tissue are
interrogated by exciting strategically oriented columns. Spectroscopic images of the
columns are acquired with high spatial and variable spectral resolution. Information about
spectral concentrations, T1 and T2 relaxation times are extracted and mapped from each
voxel of such spectroscopic images.
The second contribution of the thesis is the development of fast spectroscopic
imaging techniques. The techniques generate spectroscopic images much faster than
conventional MR spectroscopic techniques while the images are still informative. As
currently implemented, the CPMG spectroscopic imaging techniques generated images that
suitable for spectral T2 and concentration analysis in 4 minutes and 18 seconds while
conventional spectroscopic techniques need scan time of 40 minutes. The RARE
spectroscopic imaging techniques with 7 echo train generate image in 36 seconds versus 4.5
minutes for the conventional spectroscopic techniques. Limitations of existing techniques
for spectroscopic studies include long scan time, so that no spectroscopy is performed
routinely in diagnosis. The techniques developed in this thesis can be performed in short
scan times, which makes clinical spectroscopic studies practical. Also the short scan time is
an especially important advantage when performing MR examinations on very ill patients or
on children. In both cases, prolonged scan times either are not available or require increased
sedation.
The third contribution of the thesis is the development and implementation of non-
invasive methodologies on a conventional 1.5 Tesla clinical MRI scanner with standard
software and hardware configurations, which make it convenient to extract spectroscopic
information along with conventional MRI examinations. The practical significance of the
technologies is that they can be feasibly incorporated into clinical protocols to perform
spectroscopic studies on clinically important targets.
The fourth contribution of the thesis is that the new methodologies promise many
potential applications, some are demonstrated in this thesis. As very applicable tools, the
new methodologies are applied in quantification of vertebral bone marrow in lumbar spine
[25], developing bone marrow in knee [26], and brain metabolites in human. This thesis
also presents the feasibility to study the lipid chemical composition and degree of
unsaturation in fatty acids [33-38]. The suggested applications of the thesis are: (1). to
measure bone marrow compositions instead of using painful and invasive bone marrow
biopsies; (2). to monitor the response of leukemia patients to radiation therapy; (3). to study
progression of bone marrow disorders by monitoring red to yellow bone marrow
conversion with aging; (4). to identify people who are at risk of artherosclorosis by studying
lipid chemical composition; (5). to evaluate relative cerebral metabolite concentrations and
relaxation times in brain tumors during course of therapy; (6). to characterize relative
cerebral metabolites concentration in children with diffuse white matter disease.
The fifth contribution of the thesis is the design of an automated image analysis
software package [37]. The image processing software, designed in graphics user interface
format on Sun workstation, makes it convenient to extract spectroscopic information from
acquired spectroscopic images.
The final contribution of the thesis is providing the possibilities to perform dynamic
chemical shift imaging studies in vivo. Like functional MRI where many fast imaging
techniques have been developed, the fast scan spectroscopic imaging techniques are also
essential in dynamic chemical shift studies. The spectroscopic imaging techniques described
in this thesis may provide opportunities in studying dynamic chemical shift imaging [39].
In contrast to echo-planar imaging which requires specialized and expensive hardware for
fast gradient switching, large peak amplitudes and fast data acquisition [40], the techniques
in this thesis require no special hardware and software since they are implemented on the
conventional MRI scanner.
1.5 Thesis Outline
This thesis consists of seven chapters, and is organized as follows:
Chapter 1 introduce the concepts of spectroscopic imaging techniques, presents the
overview and the motivations of this thesis. Contributions to the field of MR spectroscopic
imaging are highlighted.
Chapter 2 provides some background materials that are important to this thesis,
including CPMG and RARE imaging techniques, relaxation phenomena, structure of a
conventional MR scanner, and outline of image reconstruction.
Chapter 3 presents the line scan CPMG and RARE spectroscopic techniques. It
covers image localization protocols, pulse sequence designs, k-space sampling, 2-D
Fourier transformation representation, optimization of spectral resolution, T2 relaxation
time measurement and acquisition speed. Also discussed is the practical significance of the
column selection scheme. The post processing methods for acquired spectroscopic images
are illustrated.
Chapter 4 demonstrates the applications of the techniques to quantify vertebral bone
marrow and knee bone marrow in vivo. The lumbar spine studies, consisting of a group of
healthy adult volunteers, concentrate on the cellularity measurements. The developing knee
marrow studies, consisting a group of healthy adult volunteers and a group of children,
focus on spectral characterization of red and yellow marrow and the potential to monitor
the conversion from red to yellow marrow. In both cases, the relative concentrations and
T 2 relaxation values from extensive region of bone marrow are obtained and mapped for
the major proton resonance peaks.
Chapter 5 illustrates the applications of the techniques to study lipid chemical
composition. This capacity is demonstrated on an array of oil phantoms in which lipid
spectral resonances are mapped spatially. The pulse sequences are modified with a non-
selective inversion pulse and applied to yellow marrow of a group of healthy adults. The
spectral T1 relaxation values for major lipid protons are obtained, as well as the detection
of terminal methyl protons even with a limited spectral resolution. The potential to monitor
the degree of unsaturated fatty acids in bone marrow is demonstrated.
Chapter 6 presents the applications of the techniques to study human brain
metabolites. Major metabolites in proton spectrum (N-acetyl aspartate, choline containing
compounds/creatine ) are quantified and mapped. T2 relaxation values of the NAA and
composite Cho+Cr protons are obtained from a group of healthy adult volunteers. The
improvement of signal-to-noise ratios is examined by adding data from several different
echoes. The potential to study brain disorders is demonstrated with a tumor patient.
Chapter 7 summarizes the thesis, suggests potential clinical applications, and
outlines future research possibilities.
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Chapter 2
Background
In this chapter some background materials that are essential to this thesis are briefly
presented. This chapter is organized as follows. In Section 2.1 the CPMG sequence is
illustrated. In Section 2.2 the RARE sequence is demonstrated. This is followed by a
discussion of the relaxation phenomena in Section 2.3. Then in Section 2.4 the structure of
the clinical MRI scanner used for experiments in this thesis is presented. In Section 2.5 the
way RF receiver acquires signal is described. The chapter concludes with an outline on
image reconstruction in Section 2.6.
2.1 CPMG Sequence
The Carr-Purcell-Meiboom-Gill (CPMG) sequence, or called phase shifted Carr-
Purcell, is based on Carr-Purcell (CP) sequence [1]. The CPMG may be described as a
r / 2 (+x), r, n (+y), 2 r, 7r (+y), 2 , 7r (+y), 2 , ..., sequence. The r / 2 pulse is
applied along the positive x axis and 7r pulses are along the positive y axis while in CP the
7r pulses are along x axis. The echoes are generated at 2,r, 4•r, 6r, .... In CPMG the
echoes are along the positive y axis instead of alternatively positive and negative as in CP.
CP experiment requires that pulses be reasonably accurate and that the RF pulses be
uniform over the entire sample volume. Because the RF field inhomogeneity over the entire
sample makes it quite impossible in most cases to have pulses set accurately for entire
sample, the errors in setting the 7r pulses in a CP sequence accumulate and become quite
troublesome. The advantage of CPMG over CP is that the accumulated errors due to
imperfect 7r pulses are minimized [2].
2.2 RARE Sequence
The Rapid Acquisition Relaxation Enhanced (RARE) sequence was pioneered in
1986 by Hennig [3]. With slight modifications, the sequence has been called fast spin echo
(FSE) [4, 5]. The FSE sequence is a variant of the echo planar method first proposed by
Mansfield and Maudsley [6]. A demonstration of its use for making images was first
described by Hall and Sukumar [7]. The essential difference between clinically
demonstrated FSE sequence and those methods widely referred to as echo planar imaging
(EPI) [6, 8-11] lies in the way the echoes are created. The FSE sequence utilizes RF
refocused echoes generated from a CPMG sequence while EPI methods utilize gradient
recalled echoes.
In both FSE and EPI techniques, a single excitation of the spins is followed by an
echo train during which each echo is individually phase encoded and sampled in the
presence of a frequency encoding gradient. The number of frequency encoding steps
determines the number of pixels along the read direction in the final image. Therefore,
sampling rates and desired pixel resolution along the read axis limit minimum echo spacing
in both sequences. In a single shot excitation scheme, the number of echoes following the
original excitation determines the number of pixels in the phase encoding direction. It
becomes a practical matter to attempt to acquire as many echoes as possible in a single echo
train in order to reduce data acquisition times.
In FSE sequence the echo spacings are longer than those from gradient recalled EPI
sequence. The reason is that the RF refocusing pulses take some time, especially if they are
slice selective. This lengthens the minimum spacing between echoes available in a FSE
sequence over that permitted by an EPI sequence.
In both FSE and EPI sequences, echoes are collected while natural relaxation
processes are reducing successive echo heights. The effects these relaxation processes are
two-fold: a blurring artifact in the phase encoding direction, and T2 image contrast [3, 12].
2.3 Relaxation Phenomena
The T1 relaxation, the spin-lattice relaxation time, is a measure of how rapidly the z
component of the magnetization reaches thermal equilibrium if it is displaced from its
equilibrium state by the absorption of RF energy [13]. The main feature of T1 relaxation is
an exchange of spin energy with the thermal energy of the molecules, or the lattice. Only
fast fluctuations (occur at the rate of 1 / coo or faster ) contribute to T 1 relaxation. For liquid
systems such as water, typical T1 relaxation times lie in the range of 0.1-10 second. In
solids, where the motion is considerably less, T1 relaxation times could be minutes or even
hours.
The T2 relaxation, spin-spin relaxation, is a measure of how rapidly the transverse
components of magnetization lose phase coherence. It is the process in which the transverse
magnetization in the rotating frame is destroyed. In contrast to T1 relaxation, both fast and
slow fluctuations contribute to T2 relaxation. Consequently, T2 is always equal to or less
than T1.
The T1 and T2 relaxations in vivo are complex processes to which many different
relaxation mechanisms exist: dipole-dipole interaction, J-coupling, paramagnetic,
susceptibility, diffusion, etc. Generally the T1 and T2 relaxation times are tissue specific
and have been used for characterizing certain diseases [14-17]. In vivo measurement of the
T1 and T2 relaxation times, particularly of individual spectral peaks, may provide insight in
clinical diagnosis.
2.4 Scanner Overview
The instrument used for experiments of this thesis is a standard 1.5 Tesla GE Signa
whole body MRI clinical scanner with 4.x hardware and software configuration (General
Electric Medical Systems, Milwaukee, Wisconsin). The block diagram in Figure 2.1 shows
the hardware configurations of the scanner. The hardware consists of the host computer
(Data General MV4000) connected to the transceiver processing and storage (TPS) chassis,
and the consolidated pulse control module which the pulse sequence generator boards
(PSG) are contained within. The TPS chassis consists of a 68020 CPU, and array
processor, bulk access memory, data acquisition board, the receiver and the exciter. The
PSG boards provide control of the devices and also produce 16 bit digital waveforms for
the gradient and RF amplifiers. There are six PSG boards in all: XGRAD, YGRAD,
ZGRAD, RHO (RF envelope), THETA (RF phase), and LOGIC (master board). The first
five are descriptive of the device being controlled. The last board is not descriptive and
linked to bus and controls the hardware in TPS. The LOGIC board is the master board
because when it stops all the other boards stop.
In designing new MR experiments, pulse sequence database programs (PSD) have
to be developed to control the hardware. A pulse program controls gradient boards, RF
boards, digital exciter, receiver, master board, and keeps all components operating in a
sequential order. A. pulse program also loads in appropriate frequencies, phases, order of
waveforms, as well as specifying the way data are acquired and images are reconstructed.
MR physics, computer architecture, digital hardware knowledge and computer software
skills are involved in designing and implementing new PSDs.
RF outI I RF in
hard diskhost computer display console scanplasma CRT plasma
Figure 2.1: Hardware configurations of a clinical MRI scanner.
2.5 Data Acquisition
The main structure of the RF receiver of the GE Signa scanner is schematically
shown in Figure 2.2. To understand how the data are acquired, follow the path of an input
signal from a coil, through the mixers, the anti-alias filter, A/D converter, and digital
filtering. The signal from the coil is mixed with the receiver frequency to create an
intermediate frequency signal centered at 187.5 kHz. An anti-alias filter immediately prior to
the A/D converter reduces the bandwidth of the signal to 125 kHz, again centered at 187.5
kHz. The A/D converter has 250 kHz fixed sampling rate. Since the signal is band-limited
to 125 kHz, aliasing is not a concern. The sampled signal is then broken down digitally into
inphase (I channel) and quadrature (Q channel) components which then enter separate
digital filter paths.
I Channel
I "AZ ..L 1 Q7 Z VTT
Iz
ng
Figure 2.2: Schematic representation of RF receiver of the scanner.
The sampled signal, with a frequency spectrum centered at 62.5 kHz, can also be
viewed as a low pass signal whose spectrum is reflected and centered at 62.5 kHz. To create
I
I/Q pairs in the analog domain, it would be necessary to mix this signal down to the
baseband with sin(2 r x 62.5 x t) and cos(2 r x 62.5 x t) where t is time. In digital domain,
replacing t with n/250 gives following two mixing signals: sin(nr / 2) and cos(nsr / 2). For
n = 0, 1, 2 ..., gives { 0, 1, 0, -1 } for sine and { 1, 0, -1, 0) for cosine. The task of
multiplying every other point by zero is equivalent to switching the A/D output between I
and Q channels. Thus, points sampled at even discrete time units move to the I channel, and
points sampled at odd discrete time units move to the Q channel.
2.6 Image Reconstruction Outline
This section outlines the general steps of image reconstruction. Most of the images
contained in this thesis were reconstructed on-line, though some were reconstructed off-line.
The recon routine does the following:
For each scan, build fermi (low pass) filter. For each echo, perform rational image
scaling depending on pre-scan attenuation factors and divide frame by number of
excitations. If y resolution < 256, zero fill to 256, perform frequency FFT (x-direction) and
phase FFT (y-direction). Then calculate magnitude, phase, I or Q image, as well as
Clip/Offset.
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Chapter 3
Line Scan Spectroscopic Imaging
3.1 Introduction
In this chapter, the line scan CPMG and RARE spectroscopic imaging techniques
and image analysis methods are demonstrated. This chapter is organized as follows. In
Section 3.2 the target localization sequences are presented. In Section 3.3 the line scan
CPMG spectroscopic imaging sequence is demonstrated. Also illustrated in this section are
a k-space representation and the solution of Bloch equations that is used to explain the echo
signals as the Fourier transformation image of the magnetization. Then in Section 3.4 the
line scan RARE spectroscopic imaging sequence is described. This is followed by a
discussion on optimizing spectral resolution, T2 measurements and acquisition speed
(Section 3.5). In Section 3.6 the importance of column selection is stated. The chapter
concludes with a presentation on image post processing analysis methods (Section 3.6.)
3.2 Target Localization
The imaging protocols consist of section image localization, target column
localization and spectroscopic imaging sequences. This section explains section image
localization and target column localization sequences.
Section image localization is from a set of TI-weighted section images acquired
with a standard RARE sequence (TR/TE = 600/12 ms) [1], a variation of Fast Spin Echo
imaging. A section image that contains most of the target tissues is selected, and location of
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the image slice is recorded. For in vivo studies of this thesis the target tissues are bone
marrow and brain. Within this section image, a target column is localized as the volume of
interest. Visualization of this column is achieved with a RARE based rapid scan (TR/TE =
600/75 ms, 18 sec scan time for 128 phase encodes) [2], shown in Figure 3.1. Such scan
generates a section image at the selected slice location that contains a dark band outlining the
targeted tissue column.
Figure 3.1 is the pulse sequence for rapid visualization of the target column. The
sequence is a standard RARE sequenc combined with a pre-saturation pulse. The selective
900 pulse along with a gradient on the readout direction prior to the RARE sequence
saturates the targeted tissue column in the section image. The imaging slice is excited by the
initial 900 pulse along with a slice selective gradient and refocused by the following 1800
pulses along with refocusing gradients. Each echo is individually phase encoded before
echo sampling and rephased after the sampling. Two spatial dimensions of the image are
encoded by readout gradients and phase gradients respectively. Up to eight echoes can be
collected per excitation even though only three are shown here. Eight k-space lines are
acquired per TR if the 8-echo train is used.
180 y
sat 90 x
ASG ad n n
G
phase
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phase
Figure 3.1: Saturation pulse added prior to RARE sequence. The SAT pulse saturates spins from
selected tissue column so that the column appear as a dark band in the section image.
3.3 Line Scan CPMG Spectroscopic Imaging
3.3.1 Pulse Sequence
The line scan CPMG spectroscopic imaging sequence is presented in Figure 3.2.
The initial 900 pull, a one-side-lobe since pulse of 3 ms duration filtered with a Hamming
window, along with a slice selective gradient Gread (maximum strength of 10 mT/m, 0.6
ms ramp) excites a plane that is orthogonal to the one refocused by the following 180,
n
180 y
I
.,, M M
-Z
180 y
pulses (the same as 900 except the amplitude and phase) along with slice selection gradients
G-slice
. 
The intersection of the two planes yields a column where the echo signals come
from [2, 3]. This procedure ensured that echoes are from spins restricted to a nominally
square column whose width is dictated by the RF waveforms and the maximum strength of
the slice-select gradients.
Spatial information is encoded along the column, with phase-encoding gradients
applied before echo readout and "unwound" after echo readout. In the dimension
perpendicular to the column, instead of encoding spatial information, the spectral
information is preserved without applying read gradients. Since the echoes are sampled in
the absence of frequency-encoding gradients, the Fourier transformation provides the
spectral information directly. The figure shows only three echoes even though up to eight
can be collected per excitation. Each echo generates a spectroscopic image corresponding to
different echo time.
The line scan CPMG spectroscopic imaging sequence has capacity of running in
multi-slice mode, that is a series of columns can be selected one at a time. Unless specified,
all experiments presented in this thesis were performed with a single column.
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Figure 3.2 Line scan CPMG spectroscopic imaging sequence. Echoes are collected without
readout gradient. In each excitation, same phase encoding gradient is used for
all echoes. Only three echoes are shown.
3.3.2 Column Selection
Figure 3.3 is the schematic representation of a target column formed by the
intersection of two planes, the excitation plane and the refocusing plane.
Signal
-iiv
1
yzx
Figure 3.3: The target column is selected by intersection of 90 slice-selective
plane and 180 refocusing plane. The phase encoding direction is along the column.
The echo data acquired in k-space, S(ky,xo,zo t), from the column can be expressed as,
S(ky,xo,zo,t) = ff s(x,y,z,3)v(x -x o )w(z -zo)e - ik y- i t dxdydzd3
where s(x, y, z, 3) is spin density distribution, and 3 is chemical shift. v(x - xo) and
w(z - zo) are the excitation profiles in x and z directions respectively. They are close to zero
everywhere except in a narrow intervals (+ Ax, ± Az) around chosen position (xo,zo). So
the integrals on x and z can be approximated,
ff s(x, y, z, 3)v(x - xo)w(z - zo )dxdz
fx +Ax Z +Az,,Jxoa Jz0 s(x,y,z, 8)dxdz
0 Z0Ax zO A ('
The column position is determined by center frequencies of the 90* and 180y pulse
envelopes, as well as the strength of slice selective and refocusing gradients. Assume the
central frequencies for the 900 and 180, pulses are wo + Ao 9 0 and oo + A s180
respectively with oo being resonance frequency, and let the slice-selective gradient be on x
direction and refocusing gradient on z direction, the column position (xo,zo) is decided by:
Awo90  A180
xo= , Z = GZ
For a given gradients, changing the central frequencies of the 900 and 180 pulses allows
reposition of the column. On-line column position is performed by changing two control
variables that are related to the RF frequencies. Also utilized on-line is an algorithm that
ensures the phase difference between 900 and 180, pulses remains the same whenever the
RF frequencies have changed.
3.3.3 Fourier Transformation Representation
The line scan spectroscopic CPMG images can be understood as follows: One
dimension is spatial and another is chemical shift (or spectral). Observe a transverse
magnetization m(x, y, z, 8, t) or m(y, 8, t) since the dependence on x and z has been
reduced by column configuration (Figure 3.3). Let 8 be the spectral variable and B'(y, 8)
represent field Bo inhomogeneity and susceptibility. T2 relaxation is ignored for the time
being. Now follow the magnetization at different timing in the pulse sequence of Figure 3.2:
t = 0+: m(y, 5, 0)
t = ta: m(y, 5, 0) e-iYB'ta e-i 8ta
t = ta+: m(y, 8, 0) eiYB'ta ei8ta, (spin flipped 180* )
t = tb: m(y, 8, ta) e-iyB'(tb-ta) e-i8(tb-ta)
= m(y, 8, 0) e-iyB'(tb-2t a) e-i8(tb-2t a)
t = t,: m(y, 5, t,) e-iyB'(te-tb) -tb) e-i G
= m(y, 8, 0) e-iYB'(tc-2t a) e-i8(t-2t a) e-iyy' GydT
= m(y, 8, 0) e-iYB'(tc-TE) e-i8(tc-TE) e-iyy GydT
tc < t < td: m(y, 8, tc) e-iy B' (TE-tc+t ') e-iS (TE-tc+t ')
= m(y, 8, 0) e-iyB't-it'-iyyf Gydr
= m(y, Th, 0) totalsignal is the sum from all the magnetization from the entire column:
The total signal is the sum from all the magnetization from the entire column:
s(Gy, t') =
where s(y, 8, 0) is proportional to m(y, 8, 0). Define ky = Gy•r, and reintroduce T2
relaxation term, the signal for the first echo is given by:
s(ky, t') = s(y, , 0)e- i t- ik Y e - i ) 't e - i(TE+ t' )/T 2 dyd6
noticed that at t' = 0, the field inhomogeneity gets refocused, so the inhomogeneity term
disappears. At times after the first echo,
t = te: m(y, 8, td) e-iy B '(t -t d) (e-i t e-td) eiY'Y Gyd
= m(y, 8, 0) e-iyB'(te-TE) e-iB(te-TE)
t = tq: m(y, 8, te) e -iYB'(t f tc) e-i 8(tf te)
= m(y, 8, 0) e-iyB'(tf T E) e-i (tf TE)
t = tq: m(y, 8, 0) eiYB'(tfTE) ei8(tfTE), (spin flipped 1800 )
s(y, , 0) ei't'-itYi yfd dyd6
t = th: m(y, 6, t) e-iyB'(th-tf) e-i(th-tf)eg- i y Gyd
= m(y, 6, 0) e-iyB'( 2t-th-TE) e-i8(2tfth-TE)e-ikyy
th < t < ti: m(y, 8, th) e-iyB '(2TE -th+t' ) e-iS (2TE-t h+t')
= m(y, 8, 0) e-iyB't-i8t'-ikyy, (2tf = 3TE)
By inserting the T2 relaxation, the signal for the second echo is given by:
s(ky, t') = Js(y, 3,0)e- i&- ikyy - i B' t ' e - i(2TE+t') / T2 dyd
This procedure can be repeated for the following echoes. In general, the n-th echo data
acquired can be expressed as:
S(kx,ky,k.,t) =
fJf f s(x, y, z, 6)v(x - xo)w(z - zo)e - i8t e-ikyy e - igB e - i( t+nTE)/T2 dxdydzd4
where v(y - yo) and w(z - z0o) are the excitation profiles in x and z directions respectively.
Direct inverse Fourier transformation of S(kx,ky,kz,t) would give T2 weighted
spectroscopic image.
3.3.4 Sampling in k-Space
Figure 3.4 illustrates how a CPMG spectroscopic image is acquired in k-space, the
Fourier space of S(y, 3). In an excitation, a phase gradient Gy is turned on to encode ky
before signal acquisition. A signal line in k-space is sampled from tmin to tmax without the
read gradient. The sampling time equals (tmax-tmin). A reversed phase gradient (-Gy) is
applied to "unwound" the phase. At the end of a TR period, Gy changes to a new value and
sequence is repeated. Each k-space line is an echo from the column.
51
tm;nI
m
*1
Aky =YAGydr
t
Lmax
t=O
Figure 3.4: k-space representation of signal acquisition with CPMG.
Each k-line corresponds an excitation with a distinct phase encodes.
The whole k-space is sampled sequentially. The solid line represents
the first phase encoding step, and the dashed lines (from top to bottom)
correspond the second, third, ... , phase encoding steps.
Let AGy be the step change between phase encodes, and Aky be the step change in
the consecutive k-space lines. The field of view (FOV) of phase encoding direction is
decided by 1 / Aky, and the spectral resolution is determined by sampling time or
1 /(tma x - tmin ).
3.4 Line Scan RARE Spectroscopic Imaging
3.4.1 Pulse Sequence
The pulse sequence for the line scan RARE spectroscopic imaging is presented in
Figure 3.5. The column is selected by two orthogonal planes, one is excited by the 900
pulse and another is refocused by the 1800 pulses. Phase encoding is along the column.
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Each echo is individually phased encoded before acquisition, and sampled without the
readout gradients.
90 x
M M M M
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Figure 3.5: Line scan RARE spectroscopic imaging sequences. The 90 pulse along with selective
gradient excites a plane that is orthogonal to the plane refocused by 180 pulses. Each
echo is individually phase encoded before echo sampling and "unwound" after the
sampling. The echoes are acquired without readout gradients.
3.4.2 T2 Weighting
Echoes acquired with large values of phase encoding gradients yield high frequency
components in the reconstructed image. However, these echoes suffer the substantial spin
dephasing, and are much smaller in amplitude than echoes associated with the small phase
encode gradients. The largest absolute value of phase gradient Kmax is decided by FOV and
the number of pixels in phase direction Np. The Nyquist criterion gives [1]:
FOV
The effective TE of RARE sequence is given by the time delay between the initial
excitation and the collection of the zero phase echo. So the T2 weighting can be manipulated
by changing the order of the phase encode. Figure 3.6 shows some scheme of the phase
encoding. The horizontal axis represents the sampling from -Kmax to Kmax and the vertical
axis represents the relative T2 weighting for each phase encoding step. In (a) the zero phase
occurs midway through the sampling cycle. The effective TE for this chronological sweep
is Npr where 2r" is the echo spacing. (b) shows one way to reduce T2 weighting by
rotating zero-phase-step forward in time. However, the method creates a large step change
during the sampling that may result in a rippling artifact. To avoid this, alternatives are
shown in (c) and (d). In (c) the smallest phase-encode values are on early echoes , and
alternating positive and negative phase encoding are from one echo to another. In (d) the 2-
shot RARE requires two excitations, one for acquiring the positive Ky and the other for the
negative Ky. The phase encoding scheme in (a) is limited to mapping long T2 species. The
methods of (b, c, d), the signal intensities from short T2 species can be greatly enhanced
over that obtained with (a).
(a)
I I
-K max 0 Kmax
(c)
Kmax
I - I
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Figure 3.6. Scheme of phase encode from -Kmax to Kmax. The vertical axis represents the
relative T2 weighting at each phase encode step. (a): Zero phase occurs midway through the
sampling cycle. (b): Circularly rotating the zero phase forward in time. (c): Shuffling the phase
encodes between odd and even echoes. (d): Two-shot RARE method for phase encoding.
3.5 Optimization of Spectral Resolution, Relaxation Measurements
and Acquisition Speed
In Fourier theories, the sampling time is inversely proportional to the spectral
resolution. To achieve high spectral resolution in spectroscopic imaging, one wants to use
long readout window for spectral signals. However, the long sampling window lengthens
the echo spacing, which in turn increasing the echo signal decay due to the T2 relaxation. In
addition, the prolonged TE increases the T2 weighting in the RARE imaging, and decreases
the signal-to-noise ratio for later echoes that are required for T2 relaxation time
measurements in the CPMG imaging. In designing spectroscopic imaging sequences, trade-
offs on spectral resolution, relaxation measurements and speed have to be made.
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The line scan CPMG spectroscopic imaging sequence is designed for spectral T2
measurements with variable spectral resolutions. The acquisition filters that offer variable of
echo readouts are 32, 64, 96, 128, 160, 192, 217 ms with 128 sampling points, which
correspond to apparent spectral resolution of 16, 8, 5, 4, 3.2, 2.6, 2.3 Hz respectively. For
example, a 32 ms signal readout provides the image with a spectral resolution of 32 Hz
(128 samples with 250 y sec sampling interval). The procedures of zero-filling the raw data
from 128 sampling points to 256 and performing FFT yield an apparent 16 Hz spectral
resolution. The CPMG spectroscopic sequence trades spectral resolution for spectral T 2
measurements.
The line scan RARE spectroscopic imaging sequence is designed to perform rapid
spectral mapping with the variable spectral resolutions. The optional acquisition filters are
the same as in the CPMG spectroscopic imaging. The effective TE can be manipulated by
choosing different echo train length and phase encodes. The speed is determined by the
number of echoes used per excitation. The scan time for a seven-echo-train is 7-fold less
than what is needed for the CPMG acquisition. The RARE spectroscopic sequence trades
spectral T2 measurements for acquisition speed.
In both CPMG and RARE spectroscopic imaging, the duration of echo readout
window places a limit on the minimum echo spacing. For instance, a 32 ms echo read
needs a minimum 48 ms echo spacing to accommodate the RF pulses, the gradients, and
the sampling window while a 128 ms readout window requires a minimum TE of 145 ms.
High spectral resolution can be achieved by applying acquisition filter of long echo
sampling at the expenses of large echo spacing. Control variables such as echo spacing and
echo sampling filter can be selected on-line to balance the spectral resolution, T2
measurements and speed for specific applications.
3.6 The Significance of Column Selection
It is well known that the bone marrow is abundant in long bones, such as in cervical,
thoracic and lumbar spine in upper extremity, and femur and tibal in lower extremity. The
column localization scheme is an efficient way to probe bone marrow in the long bones.
The use of orthogonal 900 and 1800 slice-selective RF pulses to select a column is very
important in practical sense. It reduces the dimensions of spectroscopic interrogated voxels
to the point at which meaningful spectra from restricted anatomy can be obtained. It also
speeds up the acquisition process so that the line scan techniques are very applicable as a
clinical tools.
The CPMG spectroscopic imaging sequence in Figure 3.2 can be extended to 2-D
chemical shift CPMG sequence. Instead of targeting a column, an image plane can be
selected by using 900- 1800pulses combined with slice selective gradient and refocusing
gradients. The 2-D spatial information can be encoded by phase gradients along Gx and G,
directions. Such modification would increase the volume coverage and generate 2-D
chemical shift images of different TE at the expenses of imaging scan time.
3.6 Image Analysis
For each spectroscopic imaging scan, raw data were acquired and reconstructed into
magnitude image on the Signa scanner. The spectroscopic images were transferred to a
SPARC 2 workstation (Sun Microsystems, Mountain View, California.) for further
analysis. An automated imaging post-processing program was used to extract and fit
spectra from each individual voxel of the images. The flow chart of this automated program
is shown in Figure 3.7.
image interface:
read in # of images to
fit, fitting parameters;
extract TE from heade
extract spectra:
strip header, extract spectra
from each voxel per image
Figure 3.7: Flow chart of the automated image processing/fitting program
The spectra were fitted with Gaussian functions instead of Lorentzian functions
because the experimental data are better fitted with Gaussian than with Lorentzian [4, 5].
This can be attributed to magnitude reconstructed image and unresolved overlapping
resonance peaks. Assume the envelope of echo signal is a Gaussian function:
f(t) = aeiPe- t2 /20 2 +iOt
and its Fourier transform is:
F((o)= aeiT(p + ei(c)-o)te-t 2/2a 2 dt
= aeie-02(o-O 0 )2 /2 +e-[t+i 2 (o- 0 )1]2 /20 2 dt
= aei'(- 2e_(_o-0)2/2 +e-x2 dx
= I~Jaoe'iPe_02(O-2 0)2 /2
The magnitude spectrum is:
M((o) = /2aoae- 2 (c-c00) 2 /2
Identifiable peaks within the spectra were fit with Gaussian line shapes using a
Marquardt non-linear least square algorithm. The spectra of early echoes were fitted with
double peak Gaussian functions of the form:
I(o) = A e- (c- o0A)2/01 + B e- (cO- oB)2/ [1]
where A and B are peak amplitudes, OA, UB are linewidths, and O0 A, WB are central peak
frequencies. When T2 relaxation made peaks too small to identify in later echoes, a single
Gaussian function was used to fit the remaining peak. Peak area, termed as S, under each
spectrum was numerically calculated by trapezoidal integrals using fitted parameters, A, B,
aA, UB, WA and WoB . The spectral peak area S, as a function of TE, were fitted with mono-
exponential function of the form:
S = So e- TET2 [2]
where So is the extrapolated peak area at TE = 0, and T2 is the transverse relaxation time.
SO is proportional to spin density, and the proportional constant depends on the hardware of
scanner. In case where absolute spin density is needed, the data could be calibrated using an
additional phantom that contains materials with known concentration. For simplicity, the
relative concentrations are calculated in this thesis. The relative concentrations for spectral
peak A and B are calculated from peak areas SOA and SOB by:
A% = SOA x 100%, B% = SOB x 100%
SOA + SOB SOA + SOB
When more than 2 peaks exist in the spectra, as in the case of knee study where
vinyl, water, methylene and methyl proton appear, the fitting program was applied on two
peaks at a time. After the absolute peak areas were computed, the relative concentration for
each peak was calculated by
A% = S0A x 100%
SOA + SOB + SOC + SOD
where SOA, SOB, Soc and SOD are extrapolated areas for peak A, B, C and D respectively.
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Chapter 4
Applications: Relative Concentrations and Spectral
Spin-Spin Relaxation in Bone Marrow
4.1 Introduction
Recall that in Chapter 3 the line scan CPMG and RARE spectroscopic imaging
techniques are described, as well as image analysis methods. The techniques were
developed and implemented on a conventional 1.5 T MRI scanner with standard hardware
and software configuration. In this chapter the applications of the techniques are
demonstrated. First, the techniques are tested on a phantom that consists of different
mixtures of agar and mayonnaise, and the MR measurements on the phantom are evaluated.
Second, some fundamental concepts about bone marrow that are relevant to the applications
of the techniques are stated. Third, the techniques are applied in vivo on bone marrow in
lumbar spine. The vertebral marrow studies focus on quantification of fat and water. Fourth,
the techniques are demonstrated on developing oor.e marrow in knee. The knee marrow
studies concentrate on characterization of red and yellow marrow with the potential to
monitor conversion of red marrow to yellow marrow by quantifying not only the water
proton but smaller lipid proton peaks as well. The spectroscopic images are analyzed to map
relative spectral concentrations and T2 relaxation times.
This chapter is organized as follows. In Section 4.2 the phantom experiment is
presented. In Section 4.3 fundamentals about bone marrow are introduced. Then the
vertebral marrow quantification in lumbar spine is described in Sections 4.4. It is followed
by a study on developing bone marrow in knee in Section 4.5. This chapter concludes with
a discussion in Section 4.6.
4.2 Phantom Experiment
To prove the capability of the techniques for fat/water percentages, a phantom of 5
vials with various mixtures of agar and mayonnaise were prepared to test correlation of MR
measured fat/water percentages [1]. The experiment was performed with a clinical 1.5 T GE
Signa Imager with the 4.x hardware and software configurations (General Electric Medical
Systems, Milwaukee, Wisconsin). The sequence was used in multi-slice mode to
spectroscopically interrogate the phantom. Five columns with 192 phase encode steps each
and TR of 2 seconds were acquired in 6 minutes and 24 seconds. The column clearly
containing all five vials was used for spectral post-processing.
In the phantom study of 5 vials with different mixtures of agar gel and mayonnaise,
the pure mayonnaise was found to be 81% fat by the MR measurement. Figure 4.1 is a plot
of the MR measured fat percentage versus that calculated based on weight percentages of
mayonnaise and agar, assuming fat is 81% in pure mayonnaise and 0% in agar. The
correlation found between MR measured fat percentage and that calculated on a weight
percentage basis is given by the following equation,
Fat %(MR) = 0.998 X Fat(Weight) + 0.70
with a correlation coefficient of 0.998.
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Figure 4.1. Fat percentage measurement of a phantom with different mixtures of
agar and mayonnaise. Horizontal axis is calculated by weight and vertical axis is
measured by MR method described in the text. The solid line is the best linear fit.
4.3 Bone Marrow Fundamentals
The purpose of this section is to present some background about bone marrow and
the biological basis relevant to this thesis. In the latter sections, the applications of the line
scan techniques to human bone marrow in vivo are demonstrated. This section contains
bone marrow anatomy and function, red to yellow marrow conversion, and marrow
disorders [2-4].
4.3.1 Anatomy and Function
ill IIIIIIIIIIII
Bone marrow is one of the largest and most important organs of the body within
the confines of the human skeleton. Except for bone, muscle, and fat, it is the largest organ
of the body by weight, approaching 3000 g in adult man and approximately 2600 g in
women. Its function is to provide a continual supply of red cells, platelets, and white cells
to meet the body's demands for oxygenation, coagulation and immunity.
The basic micro structure of bone marrow consists of a trabecular framework
housing fat cells covered with hematopoietic cells both supported by a system of reticulum
cell nerves and vascular sinusoids coursing among them. Fat cells are a major component
of bone marrow. These cells, however, differ from those at other locations in the body.
From animal studies it is known that marrow fat cells are smaller in size than those from
extramedullary sites. Despite their smaller size, the marrow fat cells display the same
metabolic activity. The size of these cells appears to be responsive to hematopoietic activity.
During periods of decreased hematopoiesis, fat cells increase their volume and number,
while during increased hematopoiesis the fat cells atrophy. The diversity and complexity of
the various anatomic, physiologic and biochemical constituents of bone marrow may be
simplified by the unifying concept of a balanced red and yellow marrow distribution.
4.3.2 Red and Yellow Marrow
"Red marrow" is considered hematopoietically active marrow involved in the
production of red cells, white cells and platelets. "Yellow marrow" is considered
hematopoietically inactive. Yellow marrow is composed predominantly of fat cells and has
an aggregate weight of approximately 1500 g in adult man and 1300 g in adult women,
thus accounting for roughly half the total bone marrow weight. Although red marrow
accounts for the other half of total marrow weight, of that marrow classified as red, half is
adipose tissue. Thus, about three-quarters of adult total bone marrow is composed of fat
cells. Red marrow fat cells may contain slightly greater concentrations of unsaturated fatty
acids.
The chemical composition and vascular supply of the two types of marrow differ in
important ways. Red marrow contains approximately 40% water, 40% fat, and 20%
protein, while yellow marrow contains approximately 15% water, 80% fat, and 5% protein.
The vascular network of red marrow can be viewed as being rich and arborized, while that
of yellow marrow is more sparse.
Conversion of red to yellow marrow occurs during growth and development and
has a predictable and orderly pattern. At birth virtually the entire fetal marrow space is
dedicated to hematopoietic (red) marrow. In the immediate postnatal period, conversion
from red to yellow marrow begins and is first evident in the extremities, like hands and
feet. This conversion progresses from peripheral (appendicular ) toward central (axial) with
respect to the skeleton as a whole and from diaphyseal to metaphyseal in individual long
bones. By the time a person is 25 years old, marrow conversion is usually complete and
the adult pattern is achieved. At this time, red marrow is predominantly concentrated in the
axial skeleton (skull, vertebrae, ribs, pelvis) and to a lesser degree in the proximal portions
of the appendicular skeleton (proximal femora and humeri). The yellow marrow is mainly
concentrated at skeleton from lower extremity (distal femora, tibia, fibula).
4.3.3 Bone Marrow Disorders
Various diseases that affect bone marrow reveal certain common pathophysiologic
patterns. These patterns can be broadly classified into five groups.
The first pattern or pathophysiologic mechanism is reconversion, that is yellow
marrow is recruited for red marrow production. It is reversal of normal marrow
conversion. The reason could be that the individual's demand for hematopoiesis exceeds
the ability of existing red marrow, a conversion of yellow to red marrow is initiated. The
causes vary from anemia to marrow replacement disorders (metastatic disease, myeloma,
myelofibrosis, etc.).
The second category is marrow infiltration or replacement, that is the normal
marrow cells are replaced with tumor cells. Leukemia, lymphoma, metastases and primary
bone tumors such as osteosarcoma, Ewing sarcoma and multiple myeloma are some
examples. Tumor cells have long T1 values and variable T2 values. T1 and T2 have been
measured and characterized for a spectrum of infiltrate diseases. In cases of childhood
leukemia, T1 relaxation values seem to be helpful in documentation of new disease, relapse
and remission.
The third group is myeloid depletion, that is all cells except fat cells disappear.
Myeloid elements (hematopoietic cells) are depleted. It is the opposite of cellular
proliferation. The marrow becomes predominantly fatty in nature. The processes include
aplastic anemia, radiation therapy and chemotherapy.
The fourth pattern is bone marrow edema. It is vascularly mediated, and resulted in
excess water in tissue. Several conditions (trauma, stress, reflex sympathetic dystrophy)
seem cause edema. The stimulus and controlling factors are not certain; however, it is
postulated that extracellular water increases and this is somehow modulated through
control of hypervascularity or hyperperfusion.
The fifth category is bone marrow ischemia, that is the opposite of edema. It may
result in subarticular osteonescrosis or metadiaphyseal bone infarction. The manifestations
of the process are a balance of progressive cell death and host response through repair.
Most vulnerable to the ischemia are the hemaopoietic cells which die in the first 6-12 hours
following the ischemic insult. Fat cells appear most resistant to ischemia, surviving for 2-5
days.
4.4 Vertebral Marrow Quantification in Lumbar Spine
4.4.1 Introduction
The objective of this section is to demonstrate the line scan CPMG spectroscopic
imaging method as an efficient and non-invasive way to characterize water and saturated fat
in vertebral marrow. Spectroscopic images from a column in lumbar spine are acquired.
The spectra suitable for fat and water peak area integration from many small voxels
throughout the extensive region of vertebral marrow are collected and post processed. The
relative concentrations of water and fat, and their spectral T2 relaxation values are
calculated. Spectral T 2 values for water and saturated-fat are mapped along the spine [5].
4.4.2 Materials
Experiments were performed with a clinical 1.5 T GE Signa scanner. A quadrature
body coil was used for transmitting and a surface "array" coil positioned beneath the lumbar
spine was used for signal reception.
Six healthy adult volunteers participated in the lumbar spine experiments. The mean
age (± standard deviation) is 33 (± 7) years. A total of 128 phase encode steps and a 2 sec
TR were used. Two signal average per excitation was used to improve signal-to-noise ratio
and to allow for the use of the no-phase-wrap option. The acquisition time was 4 minutes
18 seconds for one acquisition and 8 minutes 36 seconds for two. The column area was
5 x 5 mm 2 , and the column length was 32 cm for all the experiments. These resulted in a
voxel size of 5 x 5 x 2.5 mm 3.
4.4.3 Results
(b)
Figure 4.2. (a): A 5 mm slice sagittal image of the spine of a healthy 31-year-old
man. (b): The same slice with a vertical dark band representing the target column.
(c)
(d)
Figure 4.2. (c): Spectroscopic image (first echo) of the column obtained at
a TE of 48 ms. The spectroscopic axis is horizontal, and the water signal appears
to the left of the saturated fat proton signal (d): Spectroscoic image (second echo)
at TE of 96 ms.
(d)
Figure 4.2. (c): Spectroscopic image (first echo) of the column obtained at
a TE of 48 ms. The spectroscopic axis is horizontal, and the water signal appears
to the left of the saturated fat proton signal (d): Spectroscoic image (second echo)
at TE of 96 ms.
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Figure 4.3: Vertebral bone marrow spectra as a function of TE values of 48 ms (a),
96 ms (b), 144 ms (c) and 192 ms (d). The water peak is around 4.8 ppm and
saturated fat (methylene) peak appears around 1.2 ppm. Solid lines are the best fits
to the two-peak Gaussian function.
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The decays of the water and saturated fat proton peak areas with TE are shown in
Figure 4.4, along with theoretical fits of the data to monoexponential function given by
Equation [2].
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Figure 4.4 T2 decay curve of saturated-fat and water protons calculated from peak
area quantification at different TEs. Also shown are least square fits of the data to
monoexponential function.
From five of the six spine studies performed in healthy adult volunteers, 20-40
spectra from bone marrow per study were identified and analyzed. The results are
summarized in Table 4.1, which gives the mean spectral T2 values and relative fat and
water contents obtained for each individual, along with the inter-individual mean values. The
difference between the overall mean marrow water T2 (71 ms ± 14) and the saturated fat
proton T2 (113 ms ± 21) is significant. Overall fat content in the vertebral marrow was
48% ± 7.
Volunteer* % Water % Fat Water T2 ms Fat T2 ms
A (43) 54 + 14 46 + 14 78 ± 20 124 ± 12
B (31) 52 + 11 48 + 11 64 ± 15 95 ± 9
C (25) 57 ± 11 43 + 11 85 ± 23 137 ± 16
D (27) 40 ± 9 60 ± 9 77 ± 14 121 ± 12
E (37) 59 ± 9 41 ± 9 50 ± 13 86 ± 14
Mean±SD** 52 ± 7 48 ± 7 71 ± 14 113 + 21
Table 4.1: Calculated percentages of water and saturated fat proton peaks and their spectral T2
values in vertebral bone marrow of five healthy adults. *: Age (years) in parentheses.
**: Inter individual mean value and standard deviation (SD).
Figure 4.5 is a plot of spectral T2 values for water and saturated-fat protons as a
function of position along the spine for one of the volunteers (37-year-old man). The
intervertebral disk water T2 values tend to be higher than the saturated-fat proton T2 values.
The water T2 values in the vertebral marrow, however, are consistently shorter than the
lipid T2 values in this example as in all the other volunteers (Table 4.1).
I - I
o Disk Water
* BM Fat
* BM Water
0 a
0
gOee
Os a
****S
cP
D
0* o s°°oao • •
*
*a *l~ h
** ***oa *
100 125 150 175
Position [mm]
225 250
Figure 4.5: Plot of spectral T2 relaxation values versus position (superior to inferior)
along the spinal column for a 37-year-old man. At intervertebral disk locations, only
the water peak was analyzed and only water T2 values in these regions are shown. A
total of 39 voxels within bone marrow contributed to this data set.
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4.5 Bone Marrow Quantification in Knee
4.5.1 Introduction
Recall from Section 4.3 that the normal, progressive conversion of red to yellow
marrow with aging follows a well-established pattern. Conversion from red (cellular)
marrow to yellow (fatty) marrow results in intensity changes on T1 weighted MR images
[2-4, 6-13]. The increased fat content of yellow marrow yields higher signal intensity than
red marrow on Ti weighted image. Conventional MR images has been used to make
qualitative assessments of water/fat content in marrow during growth and development [2-
4, 6-13].
The purpose of this section is to demonstrate the line scan techniques as a
quantitative tool to monitor bone marrow conversion and to study marrow disorders. The
applications on bone marrow in knee that includes hematopieic and fatty marrow are
presented. The line scan CPMG spectroscopic imaging techniques are applied to map major
proton peaks through knees of healthy adults and a group of children. Their bone marrow
are in various stages of red to yellow conversion. Information about the lipid spectrum, not
only the water and saturted fat contents, are acquired and analyzed. The chemical
composition of both red and yellow marrow in knees and spectral T2 relaxation values are
quantified and mapped [14-16].
4.5.2 Materials
The knee studies were performed with the 1.5 T GE Signa scanner using a linear RF
transmit/receive extremity coil. At the beginning of the scan, a set of T1 weighted sagittal
scout image (TR/TE = 600 /20, FOV = 20 cm) were acquired. From this set of images, a
sagittal section including the distal femoral metaphysis (DFM), distal femoral epiphysis
(DFE), proximal tibial epiphysis (PTE) and proximal tibial metaphysis (PTM) was
selected. With in this section, a tissue column 20 cm long and 5 x 5 mm 2 in cross section
was selected. Visulizations of the column were performed with a RARE type sequence [17]
(TR/effective TE = 600 /75, 18 second scan time), as described in Chapter 3.
The line scan spectroscopic CPMG sequence was then applied to collect multiple
echo spectra along the tissue column. 128 phase encode steps, a 2 sec TR and one signal
average per excitation were used. The acquisition time was 4 minutes 18 seconds. The
resulted voxel size is 5 x 5 x 1.6 mm 3.
Eight healthy adults and eight children were recruited for the studies. The 8 adult
volunteers are between ages of 27 and 44 years (mean ± SD = 34 ± 6). One of these
volunteer had knee pain but showed no abnormal findings on the T1 -weighted localizers.
One 27-year-old woman showed some residual hematopoietic marrow in the distal femoral
metaphysis, as seen on the T1 -weighted localizers and confirmed by the spectroscopic scan.
The 8 children studied ranged in age from 2 to 16 years (mean ± SD = 9 + 5 years). The
spectroscopic imaging examination was performed as an adjunct to clinically indicated
examinations. Diagnoses were as follows: 3 meniscal tears, 1 Blount disease, 1 popliteal
cyst, 1 patellar fracture, 1 Salter II fracture of the proximal tibia. One patient had a negative
examination. In the case of the physeal fracture, bone bruises and marrow edema secondary
to trauma were observed. For all the children, special care was taken to measure and analyze
spectra from marrow regions which were deemed normal from the MR images.
4.5.3 Spectral Acquisition Results
Figure 4.6 (a) shows a sagittal scout image of the knee of a 57-year-old man. The
selected tissue column appears as a dark band on the slice image. The arrow points a
location within the proximal tibial metaphysis region where the spectra are extracted and
fitted on the following. Figure 4.6 (b) is the first echo spectroscopic image with TE of 78
(a)
(b)
Figure 4.6 (a): TI-weighted sagittal scout image of a 57-year-old man. The dark band
represents the selected tissue column. The arrow points at the proximal tibial metaphysis
region where single voxel spectra are to be extracted. (b): Frist echo spectroscopic image
with TE of 78 ms. The echo readout was 64 ms. The horizontal dimension is spectra and
vertical dimension is spatial axis.
(c)
(d)
Figure 4.6 (c): First echo spectroscopic imag with TE of 48 msec. The echo readout
was 32 ms. The arrow points to the location within the distal tibial metaphysis region
where spectra are to be extracted. (d): Second echo image with TE of 96 ms.
(c)
(d)
Figure 4.6 (c): First echo spectroscopic imag with TE of 48 msec. The echo readout
was 32 ms. The arrow points to the location within the distal tibial metaphysis region
where spectra are to be extracted. (d): Second echo image with TE of 96 ms.
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Figure 4.7: Spectra extracted from the arrow location within PTM in Figure 4.6.
Horizontal axis is chemical shift and vertical axis is spectral intensity. The circles
are MR experimental data and solid lines are expontential fits. (a): Spectra of first
echo with TE of 48 ms. (b): Spectra of second echo with TE of 96ms.
(b)
Figure 4.8. (a): Sagittal slice of the knee of a 2-year-old girl with column selection.
The arrows point to regions that correspond to distal femoral metaphysis, distal
femoral epiphysis, proximal tibial epiphysis, and proximal tibial metaphysis.
(b): First echo spectroscoic image at TE of 48 ms. Note the water contents are less
in two epiphysis than in two metaphysis.
(d)
Figure 4.8. (c): Second echo spectrscopic image at TE of 96 ms.
(d): Fifth echo spectroscoic image at TE of 240 ms.
(d)
Figure 4.8. (c): Second echo spectrscopic image at TE of 96 ms.
(d): Fifth echo spectroscoic image at TE of 240 ms.
Figure 4.10 shows single voxel spectra extracted from a 32-year-old woman (top)
and a 13-year-old boy (bottom) at locations within the DFM, DFE, PTE and PTM. The
adult bone marrow spectra show little variation with location. The metaphyseal marrow
spectra in the boy had large water peaks, making independent quantification of the
neighboring olefinic peak impossible. The epiphyseal marrow spectra more closely
resembled that of the adult spectra, with a reduced water allowing for spectra quantification
of both olefinic proton and water peaks in 6 to 4 ppm range.
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Figure 4.10: Spectra extracted from single voxels from a 32-year-old woman (top)
and a 13-year-old boy (bottom). Single voxels are located at regions of DFM, DFE,
PTE, PTM. Spectral peaks are identified with arrows.
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4.5.4 Spectral Analyses Results
Figure 4.11 demonstrates double Gaussian lineshape fits (solid lines ) of spectral
data from a voxel in epiphyseal marrow (DFE) of the 32-year-old woman at the first three
echoes. The olefinic and water proton spectral region and the alpha and methylene/methyl
proton spectral regions are shown separately for clarity (bottom and top, respectively). In
much of the metaphyseal marrow of the children, the water proton peak dominated the
olefinic and water spectral region and prohibited separate Gaussian fitting of the olefinic
proton peak (see Figure 4.9).
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Figure 4.11: Gaussian fits to the alpha and methylene/methyl region (top) and
olefinic/water region (bottom). The spectra were extracted from adult metaphyseal
marrow of a 32-year-old woman at the first three echoes (TE: 48, 96, 144 ms).
Typical spectral peak areas averaged over 10 to 20 voxels within metaphyseal
marrow are plotted as functions of echo time in Figure 4.12 (a) and (b) along with best fits
of the decay curves to Equation [2] (solid lines). In the adult yellow marrow, water peak
areas were generally quantifiable for between two to four echoes (a). The alpha and olefinic
proton peak areas were generally quantifiable for between 3 to 6 echoes (a). The
methylene/methyl peak areas were quantifiable for all 8 echoes in both adults and children
(b). In most of the metaphyseal marrow of the children, the olefinic peak was not
quantifiable due to the dominance of the water peak. In these cases, the composite
water/olefinic proton peak was quantifiable for between 5 and 8 echoes (b).
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Figure 4.12. (a): Peak area decay with TE as averaged over 10 voxels in the
metaphysis of a 38-year-old man for olefinic protons (squares), water protons
(triangles), and alpha protons (diamonds). The solid line is the least squares
fits of the data with a mono-exponential decay function. (b): Methylene/methyl
peak area decay from metaphyseal marrow in the 38-year-old man (diamonds)
and in a 13-year-old boy (squares). The water peak area decay from the boy is
also plotted (triangles) and, unlike the adult yellow marrow water peak (triangle
in (a)), is quantifiable for seven echoes and has a substantial amplitude when
extrapolated to TE = 0.
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Figure 4.13 maps concentrations at zero TE and T2 values of water and
methylene/methyl peaks of the 2-year-old girl in Figure 4. 8. (a) plots methylene/methyl and
water extrapolated peak areas as a function of pixel position along the column. The pixel
positions are 1.6 mm apart. The two strong lipid peaks positioning around pixel #90 and
122 correspond to the DFE and PTE. In DFM, at pixel location to the left of DFE, water
concentration exceeds lipid concentration, a situation that is reversed in the PTM (pixel
location 140-200). (b) is the T 2 map along the column for the methylene/methyl peak (solid
line) and water peak (dashed line). In general, the water peak T2 values are less than the
methylene/methyl T 2 values, in agreement with the overall spectral T2 values reported in
Table 4.2 on the following.
Table 4.2 summarizes spectral transverse relaxation T2 (mean ± standard
deviation) found in the adults and children.
Olefinic Water Alpha Meth
Adults 97 ± 28 82 + 25 78 + 17 105 ± 26
Children 83 ± 26 73 ± 22 70 ± 20 95 + 22
Table 4.2: Mean (± SD) transverse spectral relaxation times T, in ms for the four quantifiable
peaks (Meth = methylene/methyl).
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Figure 4.13: Quantitative analyses of water and methylene/methyl peaks of
the 2-year-old girl in Figure 4.7. (a): Plot of methylene/methyl (solid line) and
water (dashed line) extrapolated peak areas as a function of pixel position along
the column. The pixels are 1.6 mm apart. (b): T2 map for methylene/methyl peak
(solid line) and water peak (dashed line) along the column.
Figure 4.14 (a) and (b) present the extrapolated peak areas, expressed as
percentages, for the regions sampled in the distal femoral metaphysis (top) and distal
femoral epiphysis (bottom) for both the adults (a) and children (b). For each subject,
olefinic proton (open bars), water proton (filled bars), alpha proton (left diagonal), and
methylene/methyl proton (right diagonal) peak areas are plotted. The horizontal axis
represents the subject number. Age/sex of these subjects in (a) are: 1: 38/M; 2: 32/F; 3:
38/F; 4: 44/M; 5: 39/F; 6: 35/M; 7: 35/F; 8: 27/F. In (b) age/sex are: 1: 2/F; 2: 8/M; 3: 9/F;
4: 1 1/M; 5: 12/M; 6: 13/M; 7: 14/M; 8: 16/F. Asterisks indicate that separate quantification
of olefinic protons and water protons was not possible, and the percentage shown
represents the combined water and olefinic contribution.
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Figure 4.15. (a): Sagittal slice of the knee of a 27-year-old woman. The selected
column, 5 by 5 mm squared, is a dark strip in the image. (b): First echo spectroscopic
image with echo readout of 32 ms and echo spacing of 48 ms. The arrow points
at distal femoral metaphysis where some residual red marrow is observed.
(c)
(d)
Figure 4.15 (c) (d): First echo spectroscopic image with echo readout of 64 ms (c) and
96 ms (d). The echo spacings are 78 and 113 ms respectively. The arrow points at
the residual red marrow at the distal femoral metaphysis region.
(c)
(d)
Figure 4.15 (c) (d): First echo spectroscopic image with echo readout of 64 ms (c) and
96 ms (d). The echo spacings are 78 and 113 ms respectively. The arrow points at
the residual red marrow at the distal femoral metaphysis region.
4.6 Discussion
4.6.1 Technical Aspects
This chapter has demonstrated the new in vivo proton MR spectroscopic imaging
methodologies. The techniques provide measurements of intravoxel major proton content
and spectral T2 values throughout extensive regions of bone marrow. Since there are other
MR techniques that have been used to obtain similar measurements, it is useful to compare
the various methods from technical point of view.
Dixon/Sepponen techniques [20-22] have been used to estimate intravoxel fat/water
content in lumbar spine [23-25]. A major advantage of these techniques is that data are
collected in full image matrix formats with high spatial resolution and large volume
coverage. A disadvantage is the low spectral resolution. Essentially, two-point spectra
represented by "in-phase" and out-of-phase" images are added or subtracted to yield pure
"fat" or pure "water" images. Additional images that are not in or out phase may be
collected to correct for problems associated with the inherently limited sampling of the
spectral dimension [22]. The cost is additional imaging time and more sophisticated post-
processing. Corrections for different spectral relaxation times may be made by obtaining
data sets at different TR and TE values [23-26]. However, to save time, the relaxation
measurements are generally based on two-point analyses [23-25] and thus may lack
accuracy [27, 28].
A technique at the opposite extreme from the Dixon/Sepponen approach is the
single-voxel spectroscopic localization approach [29-31]. Here, a high resolution spectrum
is acquired from a selected voxel in 3-5 minutes. Although the method is limited in the
amount of tissue that can be studied in reasonable examination times, the spectral resolution
is on the order of 1 Hz, making peak area quantification extremely accurate. Thus, spectral
peaks other than the water and saturated fat protons can become available for analysis.
Sequence parameters can be adjusted so that corrections for differences in spectral relaxation
times to the fat/water percentages are minimal [29].
The line scan methods introduced in this thesis represent a compromise between the
high-spatial, low-spectral resolution of the Dixon/Sepponen technique and the high-spectral,
low-spatial resolution of the single-voxel spectroscopic approach. The spectral resolution is
not as good as it is in the latter method, although it is clearly sufficient to quantify 4 major
proton peaks at 1.5 T (Figure 4.7). Many more voxels are sampled than with the single-
voxel approach, although not nearly as many as are sampled with Dixon/Sepponen
techniques. On the other hand, when addressing the issue of bone marrow cellularity, most
of the voxels acquired with Dixon/Sepponen imaging methods are superfluous. In this
context, proper placement of tissue columns with inner-volume techniques allows extensive
coverage of voxels specifically within bone marrow while maintaining the essential features
of the single-voxel spectroscopic examination. Also, eight TEs are sampled, allowing more
accurate evaluation of spectral T2 values than is possible with two-point methods [28]. Use
of the relative of long TR of 2 seconds minimizes T 1 saturation of the spectral peaks [29].
The susceptibility induced frequency shift (shown as spectral curvature in Figure 4.
15 (d)) would cause dephasing and line broadening if a large voxel is localized as in single
voxel spectroscopy. The column localization helps to minimize such dephasing by choosing
a smaller voxel and more spatial sampling than volume localized spectroscopy since the
inter voxel shift appears as curvature. However, the susceptibility shift slightly varies the
voxel localization along the column. For a 0.5 ppm frequency shift, the spatial variation is
about 0.08 mm or about 2% for 5 mm thick column and a gradient strength of 1 gauss/cm.
The line scan techniques have been designed to take advantage of scanner setup and
bone marrow distributions in human. For applications not amicable for column localization,
the line scan techniques can either be expanded to 2-D CSI with CPMG or RARE by
adding another phase encoding along Gx direction (Figure 3.2) or provide a rapid and/or an
initial spectroscopic assessments combining with other CSI techniques.
4.6.2 Studies on Vertebral Marrow
The vertebral bone marrow studies focus on quantification of the water and saturated
fat protons. Since all three methods mentioned above have been used to study vertebral
bone marrow in adult volunteers, it is of interest to compare respective results with regard to
relative fat and water contents.
Rosen et al [23] used the Dixon/Sepponen method in lumbar spine studies of six
healthy volunteers ranging in age from 21 to 47 years. They reported the fat content as 29%
± 6 in healthy vertebral bone marrow and have used this figure in later studies comparing
healthy marrow with marrow from selected patient populations [24, 25]. In more recent
studies using Dixon/Sepponen methods, a larger range of fat percentages have been
reported, with a trend toward increased fat with age. For instance, Kauczor et al reported a
fat content of 41% ± 13 in a healthy population with a mean age of 33 years [32].
Schick et al applied the single-voxel approach to study the spines of 15 healthy
volunteers ranging in age from 20 to 68 years and reported fat/water ratios of 0.35 - 5.4
[33]. These ratios correspond to a range of 26% - 84% fat. We have now applied our
techniques to the problem and have measured mean intravoxel percentages of fat ranging
from 40% to 60% within the vertebral bone marrow of five healthy adult volunteers. The
interindividual mean of 48% ± 7 is higher than that reported by Rosen et al [23] but is
consistent with values reported by Kauczor et al and Schick et al [32, 33].
In addition to intravoxel estimates of relative fat and water contents, we have
measured the spectral T2 values of water and fat within vertebral marrow. The mean Tz
value for water in the marrow (71 ms ± 14) is longer than the 52-64 ms range reported by
Rosen et al [23]. This may be the consequence of a reduced contribution to T2 decay due to
diffusion of water within local field inhomogeneities, stemming from the use of multiple
1800 pulses [34]. The mean lipid T2 value in vertebral marrow was 113 ms ± 21. Again,
this is longer than the 56-98 ms range reported by Rosen et al [23] and may be due to the
use of multiple 1800 pulses, which are known to effectively lengthen T2 decay in J-coupled
spin systems [34-36]. The statistically significant difference between the water T2 and
saturated fat proton T 2 indicates that extrapolation of peak areas to zero TE is necessary if
meaningful fat/water percentages are to assessed.
4.6.3 Studies on Developing Knee Marrow
The line scan techniques are not limited to quantification of two primary peaks,
water and saturated fat, as discussed in lumbar spine section. Other major lipid peaks can
also be observed. As demonstrated in section 4.5, four peaks (water, methylene/methyl,
olefinic, alpha) are quantified in yellow marrow spectra even with limited spectral
resolution. Two of them are composite peaks [18, 19] in healthy adult yellow marrow. In
developing knee marrow in children, insufficient conversion of red to yellow marrow in the
metaphyses often made the olefinic peak unquantifiable due to the large overlapping water
resonance. When the combined water/olefinic proton peak dropped to approximately 20 %
of the spectrum, as in most epiphyseal marrow of the children studied, the two
contributions were separately resolvable. Our spectral finding are qualitatively consistent
with the known pattern of red to yellow marrow conversion. In each bone, the conversion
begins in the epiphysis, followed by diaphysis and lastly the metaphysis. In each extremity,
the conversion occurs from the periphery (fingers and toes) to the center. Thus, in the knee
the expected conversion sequence is proximal tibial epiphysis -- distal femoral ephiphysis
--- proximal tibial metaphysis -- distal femoral metaphysis. The finding of less water in
epiphseal marrow than metaphyseal marrow in the children 8 to 16 year old is consistent
with this pattern. The extrapolated peak areas mapping for mthylene/methyl protons and
water for 2-year-old girl (Figure 4. 13) are also in accord with the accepted pattern of
conversion from periphery to center [3, 4].
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It is possible that longer echo readouts within the CPMG trains will help resolve
olefinic and water peaks in red marrow, help differentiate peaks currently unresolved within
the alpha peak, and help resolve methylene from methyl protons. However, longer echo
readouts entail longer echo spacing in the CPMG trains which will, at the very least,
increase signal loss from T2 decay process. It is equally important to note that there are
several physical mechanisms in bone marrow which make the spectral T2 relaxation
behavior depend upon the echo spacing chosen. The T2 decay of water is influenced by
diffusion within magnetic field inhomogeneities generated by susceptibility differences
between trabecular bone and bone marrow [35, 37]. This can shorten effective water T2
values at longer echo spacing, potentially limiting water detectability and quantification. For
the lipid components, multiexponential relaxation [38] from composite peaks and amplitude
modulations due to J-coupling interactions [36, 39-41] influence the observed T2 behavior
in an echo spacing dependent manner. In this work for instance, we consistently found that
olefinic proton peak area estimated from the fourth echo was consistently as large or even
larger than that calculated from the third echo (Figure 4. 12), a feature we attribute to J-
coupling.
Consideration of these complexities underscores an important feature of the CPMG
spectroscopic imaging technique. Namely, though the method yields both spectroscopic and
T2 relaxation information, there exists a fundamental tradeoff between these two types of
information. Further studies will be useful for evaluating the advantages and limitations
associated with different CPMG spectroscopic imaging parameters for studying the
complex spectroscopic and relaxation characteristics of protons in both red and yellow
marrow.
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Chapter 5
Applications: Lipid Chemical Composition
5.1 Introduction
Recall in Chapter 4 the spectroscopic studies on the developing knee marrow
concentrated on water and major lipid protons while the studies on vertebral marrow
focused on quantification of water and saturated-fat protons. High resolution MR
spectroscopy shows that the lipid protons have at least eight resonance peaks [1, 2] with
different T1 and T2 relaxation. Conventional MR images represent only "bulk" signal
intensities, which reflect the sum of signals from all the mobile protons within a given
volume element. Since a voxel in the fat-containing tissue such as bone marrow contains the
lipid and water protons, the changes of the chemical composition in the voxel can not
readily be distinguished from changes in the "bulk" relaxation time measurements [3].
The line scan spectroscopic imaging techniques provide the possibility to estimate
T1 and T2 relaxation times of some resolved lipid resonances in the 1H spectrum. The aim
of this chapter is to demonstrate the feasibility of quantifying lipid chemical composition.
Specifically, the spectroscopic imaging techniques are performed on bone marrow in vivo
and on various oil samples. Quantification of the small lipid resonance peaks includes
estimation of spectral T1 relaxation values, detection of terminal methyl protons, mapping
of fat unsaturation, and study of the levels of mono-unsaturated versus poly-unsaturated
triglycerides.
The organization of the chapter is as follows. Section 5.2 provides a background
about lipid proton resonances in 1'H spectra expected in vivo. Section 5.3 presents the
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application of the line scan spectroscopic imaging techniques on an array of oil phantoms ,
and illustrates the oil spectra. Then the measurement of lipid spectral T1 relaxation times in
knee marrow with inversion recovery RARE spectroscopic imaging are presented (Section
5.4). Section 5.5 demonstrates the studies on monitoring the degree of unsaturation in
triglycerides. The chapter concludes with a discussion (Section 5.6).
5.2 Lipid Proton Resonances
The purpose of this section is to introduce some background about lipid proton
resonances in 1H spectra and their chemical shift values [1, 2, 4, 5].
Lipid protons consist mainly of triacylglycerols (TAG), that is esters of the alcohol
glycerol with three fatty acids. TAGs fill almost the entire fat cell volume. In human
organism TAGs are found under the skin, in the abdominal cavity, in the mammary glands,
and in the bone marrow. In contrast to water protons, lipid protons within TAG molecules
are chemically distinct and give rise to at least eight resonance peaks with different T, and
T 2 relaxation times in the 1H MR spectrum. Figure 5.1 shows the main structural feature
of a TAG molecule.
H O(3) 1 II
H-C- O- C- R 2
(2)
H-C- O- C- R 1
H- C-O- C- CH -CH 2- (CH 2 )-CH2- CH=CH-CH2-CfI-CH- CH2 -(CH 2 )CH
H (5) (9) (7) (6) (1) (1) (4) (1) (1) (6) (7) (8)
Figure 5.1: Chemically distinct lipid protons of triacylglycerols.
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The assignments and the chemical shifts of the resonances are summarized in Table 5.1.
Resonance Number * Assignment 8 (ppm) **
1 olefinic protons 5.4 - 5.6
2 CH of glycerol backbone 5.1
3 CH 2 of glycerol backbone 4.2
4 diallylic CH 2 2.8 - 3.0
5 CH 2 , a to carboxyl 2.3 - 2.5
6 CH 2, a to double bond 2.0
7 CH 2 of aliphatic chain 1.3
8 terminal CH 3  0.9
9 CH 2 , 2nd next to carboxyl 1.5
H 20 4.7
Table 5.1: Assignments and chemical shifts of proton resonances in lipids.
*: Resonances are numbered as in Figure 5.1. **: Chemical shift are relative to TMS.
5.3 Lipid Spectrum in vitro
To demonstrate the techniques with regard to quantification of lipid spectra, a
phantom of 5 vials with various mixtures of fish oil and mineral oil was made. The line
scan CPMG spectroscopic imaging techniques were applied on this array of oil with the 1.5
T GE clinical scanner. The spectroscopic images were acquired and the lipid resonance
peaks stated in the previous section were identified. The scan parameters used were: TR of 2
s, 64 ms spectral read out, 20 cm FOV, 128 phase encoding steps, 1 signal average. The
resulted voxel size is 5 x 5 x 1.6 mm 3 . The scan time was 4 minutes and 18 second for the
8-echo CPMG sequence, and 1 minute and 26 second for the 3-echo RARE sequence.
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(a).
(b).
Figure 5.2. (a): An array of phantoms that are mixtures of fish oil and mineral oil.
The weighted percentages for each phantom are (from top to bottom): 100% fish
oil, 75% fish and 25% mineral oil, 50% fish and 50% mineral oil, 25% fish and
75% mineral oil, 100% mineral oil. (b): First echo CPMG spectroscopic image with
TE of 78 ms. The echo readout is 64 ms. The arrow points where spectra are extracted
from pure fishoil.
110
(c).
(d).
Figure 5.2. (c): Second echo CPMG spectroscopic image with TE of 156 ms.
(d): 3-echo train RARE spectroscopic image with effective TE of 156 ms. The
phase artifact that appears as blurring along the vertical direction is caused by
different T2 weighting for each phase encoding step in the echo train.
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Figure 5.2. (c): Second echo CPMG spectroscopic image with TE of 156 ms.
(d): 3-echo train RARE spectroscopic image with effective TE of 156 ms. The
phase artifact that appears as blurring along the vertical direction is caused by
different T2 weighting for each phase encoding step in the echo train.
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Figure 5.3 shows the first and second echo spectra extracted from a voxel of pure
fishoil denoted by the arrow in Figure 5.2 (b). The numbers in the graph represent the
resonance peaks defined in Section 5.2. Peak #1 is assigned as the olefinic proton (-
CH=CH-) at 5.6 ppm, peak #4 is the proton in between the double bonds (=C- CH2 -C=) at
2.9 ppm, peak #5 is the proton that adjacent to carboxyl (O=C- CH 2 -) at 2.4 ppm, peak #6
is the proton that cc to double bond (-C=C- CH 2 -) at 2.0 ppm, peak #7 is methylene proton
(-CH2 -)n at 1.2 ppm, peak #8 is terminal methyl (-CH3 ) at 0.9 ppm, peak #9 is the
proton second next to carboxyl (O=C- CH 2 -CH 2 -) at around 1.5 ppm.
1000
750
500
250
0
7 6 5 4 3 2 1 0 -1
PPM
Figure 5.3: Spectra extracted from pure fishoil at the arrow location as in Figure 5.2(1
for the first and second echoes with TEs of 78 ms and 156 ms. The numbers represent tht
resonance peaks defined in Section 5.2.
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5.4 Inversion Recovery Spectroscopic Imaging: Lipid T1 Relaxation
Time and Terminal Methyl Detection
5.4.1 Introduction
This section presents the inversion recovery line scan RARE spectroscopic imaging
techniques and their applications in vivo and in vitro. The lipid T1 relaxation times in healthy
adult yellow marrow were measured. Inversion pulse nulls the methylene signal and the
terminal methyl signal is detected even with a limited spectral resolution (echo readout) [7].
In vivo methods for mapping spectral relaxation times and relative concentrations of
methyl, methylene, and olefinic protons contain information related to triglyceride chain
lengths and unsaturation. If performed in clinically acceptable scan times, they may prove
useful for diagnosing or non-invasively monitoring disorders of lipid metabolites. To
characterize T1 values for lipid signals in bone marrow, the line scan RARE spectroscopic
imaging technique described in Chapter 3 was modified with an inversion preparation pulse.
As in short-tau inversion recovery imaging technique [8], a non-selective 180' pulse is
placed before the regular line scan spectroscopic sequences. For each inversion time (TI),
spectra from 128 voxels along the selected tissue column were acquired in 1.5 minutes.
Data from over 10 TIs were acquired for spectral T1 relaxation analysis in under 20
minutes. At a properly chosen TI, the inversion recovery nulls the large methylene signal in
yellow marrow. Therefore the relatively smaller terminal methyl signal is detected even with
the limited spectral sampling window required for multiple spectroscopic echo collections.
5.4.2 Materials
Studies were performed on a 1.5 T GE Signa system. The line scan RARE
spectroscopic imaging sequence consisted of a 3 echo train, 48 ms echo spacing and 32 ms
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echo readout. The sequence was preceded by a non-selective 1800 pulse with a variable TI.
Mutually orthogonal slice selective excitation and refocusing pulses confined the
spectroscopic echoes (32 Hz resolution zero filled to 16 Hz) to spins within a 5 x 5 mm 2
column. The dimension along the column (FOV of 20 cm) was encoded using distinct
phase encode gradients for each echo, yielding 3 k-space lines per TR. The lowest phase
encode gradients were assigned to the second echo, resulting in an effective TE of 2 x 48 =
96 ms. A TR of 2 second and a total of 128 phase encodes resulted in a scan time of 1
minute and 26 seconds.
Data sets were collected form columns parallel to lower extremity long axis centered
on the knees. Four healthy volunteers were studied using up to 14 TI values from 50 to
1200 ms. Olefinic and methylene peak areas from over 50 voxels of yellow marrow for
every volunteer were measured as functions of TI to estimate T1 values. In vitro studies of
fish oil (Natures Bounty, Bohemia, NY) and corn oil (Mazola, CPC international, Cliffs,
NJ) were also performed.
5.4.3 Results
Figure 5.4 shows the methylene and olefinic proton intensity (peak area) in bone
marrow of a 55-year-old healthy man versus inversion time. (a) is inversion recovery T1
relaxation curve for methylene protons and (b) is olefinic proton. The error bars come from
averaging of a few voxels in bone marrow along the tissue column. The solid lines
represent a best non-linear fit of the form: y = M1 - M2 exp(-x / TI), where M 1 stands for
the initial magnetization after the inversion pulse. The fitted T1 (mean ± SD) is 288 ±7 ms
for methylene proton and 460 ± 98 ms for olefinic proton.
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Figure 5.4: Signal intensity (peak area) versus inversion time in bone marrow
of a 55-year-old man. (a). The methylene proton. (b). Olefinic (vinyl) proton.
The solid line is a best non-linear fit to the data with y= ml- m2*exp(-x/T1).
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Table 5.2 reports methylene and olefinic proton T1 values of healthy adult yellow
marrow and the two oil samples. The methylene T1 in marrow was found to be slightly
longer those found in the oils. The marrow olefinic proton T1 was intermediate to those
found for the different oils. The longest olefinic proton T1 values were observed in fish oil,
consistent with a higher degree of unsaturation (high in w-3 fatty acids) and subsequent
increased fluidity [6]. The methylene peak contains a small contribution from terminal
methyl protons. The methyl peak was observed in all subjects at TI values which adequately
nulled methylene signal.
Methylene Proton Vinyl Proton
Yellow Marrow 274 ± 27 ms 348 ± 84 ms
Corn Oil 227 ± 11 ms 233 + 27 ms
Fish Oil 202 ±12 ms 476 ± 39 ms
Table 5.2: Methylene and vinyl proton T 1 values of healthy adult yellow marrow and
samples of fish oil and corn oil.
Figure 5.5 illustrates the in vivo marrow spectra acquired at TI values of 160 to 200
ms. The persistent signal at 0.9 ppm as the large methylene peak passes through a null is
attributed to terminal methyl protons with unspecified, but longer, T1 values as compared to
methylene protons. Note from TI of 160 ms to 180 ms, the methylene peak is nulled
gradually. At TI of 180 ms, the inversion pulse nulls the methylene peak almost completely
and the methyl peak dominates the spectral range between 0 to 2 ppm.
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Figure 5.5: In vivo yellow marrow spectra at TI values 160, 170, 180,190 and 200ms,
bottom to top. Spectra are extracted from each voxel of 0.04 cc and averaged over neighbouring
four voxels. The signal at 0.9 ppm is attributed to terminal methyl protons as the methylene
protons pass through a null around TI = 180 ms.
(a).
(b).
Figure 5.6. (a): A sagittal slice of the knee from a 55-year-old man. The column
selection appears as a dark band. (b): 3-echo-train RARE spectroscopic image
with a non-selective inversion pulse. TI is 190 ms. The effective TE is 96 ms and
the echo readout is 32 ms.
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Figure 5.6: First echo (c) and second echo (d) CPMG spectroscopic image
with a non-selective inversion pulse. TI is 190 ms and the spectral read out
is 32 ms. TEs are 48 ms for (c) and 96 ms for (d).
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Figure 5.6: First echo (c) and second echo (d) CPMG spectroscopic image
with a non-selective inversion pulse. TI is 190 ms and the spectral read out
is 32 ms. TEs are 48 ms for (c) and 96 ms for (d).
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Figure 5.7 is the spectra for the first four echoes extracted from the arrow location in
Figure 5.6 (c). The TEs are 48, 96, 144, and 192 ms for four echoes respectively. The
spectra are extracted and averaged over neighboring 4 pixels to increase the signal-to-noise
ratio. Note that methylene peak (1.3 ppm) decays faster than methyl peak (0.9 ppm), which
implies methyl protons have a longer T2 value than methylene protons.
50
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Figure 5.7: The spectra extracted from the arrow location. The inversion pulse
nulls the methylene peak (1.3 ppm), so methyl peak (0.9 ppm) is visible even for
32 ms spectral read.
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5.5 Assessing Triglyceride Unsaturation
5.5.1 Introduction
This section demonstrates the line scan CPMG spectroscopic imaging techniques in
assessing the degree of triglyceride unsaturation in vivo and in vitro [9, 10].
Non-invasive assessment of triglyceride chemical compositions in vivo may be
useful for monitoring patients with abnormalities in fat absorption and metabolism. Several
investigators have discussed the clinical significance of measuring the degree of
unsaturation among triglycerides for monitoring dietary compliance in patients with
vascular disease or for assessing abnormal fatty acid metabolism in cystic fibrosis patients,
using 13C NMR [11-13]. In addition to overall unsaturation, 13C can also be used to
measure the degree of mono- versus poly-unsaturated fatty acids. However, the low
sensitivity makes extensive tissue sampling difficult in clinically acceptable scan times at
routine imaging field strengths [11].
The line scan CPMG spectroscopic imaging techniques are capable of measuring
an index which associated with the degree of unsaturation in triglycerides. The index is the
ratio of olefinic proton signal to combined methylene /methyl proton signal. The rationale
is that the olefinic proton peak arises solely from unsaturated fatty acids while the
methylene/methyl peak arises from both saturated and unsaturated fatty acids. For every
double bond created in the triglyceride aliphatic backbone, two protons are added to the
olefinic signal and four protons are directly removed from methylene signal. Therefore, the
ratio of these two peaks is sensitive to the overall degree of unsaturated versus saturated
fatty acids.
The techniques were applied to yellow marrow of healthy adult volunteers from
which the index in many small voxels within yellow marrow was measured. Control
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values for olefinic to methylene/methyl ratios in healthy adult yellow marrow are reported.
The sensitivity of the ratio to degree of triglyceride unsaturation is demonstrated in vitro.
5.5.2 Materials
Foton spectroscopic imaging was performed with the 1.5T GE Signa scanner
using a 8 echo line scan CPMG spectroscopic imaging sequence. Each echo was phase
encoded for spatial information along the selected tissue column and unwound following
readout in the absence of gradients. Final data sets consisted of spectra from 128, 5 x 5 x
1.6 mm3 voxels along the column at echo time from 48 to 384 ms with a spectral
resolution of 32 Hz zero filled to 16 Hz. Acquisition time was 4 minutes and 18 seconds
using a 2 s TR and 128 phase encodes. The knees of 8 healthy adult volunteers were
studied. Multi-echo spectra from voxels within marrow were fitted with Gaussian
functions. Peak percentages were calculated from peak areas extrapolated to zero echo time,
accounting for spectral T2 decay differences as described in Chapter 3. The spectral
assignments of olefinic, water and methylene/methyl peaks are the same as in Section 5.2.
The alpha peak refered in this section is a composite lipid peak at 2.4 ppm. In vitro studies
of fish oil and corn oil were also performed. High resolution proton 1H spectra of the oils
were obtained at 7 Tesla with a GE vertical bore spectrometer to confirm differences in the
overall degree of unsaturation and for comparison with 1.5 Tesla proton spectroscopic
imaging.
5.5.3 Results
Percentage contributions to the healthy adult yellow marrow spectra, as averaged
over 8 volunteers and over 50 marrow voxels per volunteer are shown in Table 5.3. The
olefinic to methylene/methyl extrapolated peak area ratio was 0.08 ± 0.02.
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Olefinic Protons
Water Protons
Alpha Protons
Methylene/Methyl Protons
Percentage (average ± SD)
6.4 ± 0.4 %
4.2 ± 1.5 %
7.2 ± 0.5 %
82.2 ± 1.9 %
Table 5.3: Relative percentage of proton peak areas in adult yellow marrow.
The percentage values are the average of 8 healthy adult volunteers.
Table 5.4 reports the ratio of olefinic peak area to combined methylene/methyl peak
area for fish and corn oil obtained in 7 T 1H spectrometer and 1.5 T clinical scanner. The
measurements at high field (7 T) and conventional field (1.5 T) 1H spectroscopy
confirmed the presence of more unsaturated fatty acids in fish oil than in corn oil.
Spectroscopy Spectroscopic Imaging
at 7 T at 1.5 T
Corn Oil 0.14 0.13 + 0.01
Fish Oil 0.26 0.24 ± 0.02
Table 5.4: The ratio of olefinic peak area to methylene/methyl peak area in oil samples. The
listed ratios are obtained from spectroscopy measurement on a 7 T spectrometer and line scan
CPMG spectroscopic imaging measurement on a 1.5 T clinical scanner.
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5.6 Discussion
Previous proton spectroscopic studies of bone marrow have focused assessing
water versus saturated fat content for monitoring hematologic disease [14]. Assessing lipid
chemical composition non-invasively may have even more widespread utility from an
overall medical perspective [15]. Though single voxel proton spectroscopy may be applied
towards this end [5, 14], the advantage of a line scan spectroscopic approach is increased
volume coverage and reduced voxel size, the latter being useful for minimizing
susceptibility induced intra-voxel dephasing in studies of marrow within trabecular bone
[14].
Spectral T1 relaxation measurements of lipid peaks in yellow can be made
throughout the knee in many small voxels in reasonable scan times using spectroscopic
RARE techniques. Spectral resolution is limited and can only be improved at the expenses
of increased T2 weighting because longer readouts increase echo spacing. As such, the
small methyl peak adjacent to the large methylene peak was previously unresolved with 32
ms readouts [16]. Inversion pulses at TIs similar to those used for STIR imaging [8] allow
for methyl signal observation even with the limited spectral resolution required for
spectroscopic RARE acquisitions. Nulling the methylene signal in this manner allows for
T2 measurement of the methyl signal at relatively short echo spacings with CPMG
spectroscopic sequence.
As currently implemented, the line scan techniques provide a measure of the ratio of
olefinic to methylene/methyl protons in yellow marrow, a chemical index sensitive to the
degree of unsaturation among the triglycerides. In most red marrow sampled, however, the
spectral resolution afforded by the 32 ms echo readouts was not sufficient to separate
resolve the olefinic proton contribution from the dominant water peak. Better spectral would
be required for this task as well as for assessing the degree of mono - versus poly-
unsaturated triglyceride levels. In this case, a peak at 2.8 to 3.0 ppm from CH 2 groups
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between double bonds [5] must be resolved and quantified, thus allowing for a
measurement of a proton peak arising solely from polyunsaturated fatty acids. With the
present spectral resolution, this peak is just one of several resolved peaks contributing to the
alpha peak.
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Chapter 6
Applications: Human Brain Metabolites
The studies in previous chapters were mainly on bone marrow, designed to
quantification of the cellularity and the lipid chemical composition. In this chapter the line
scan CPMG and RARE spectroscopic imaging methods, implemented on the standard 1.5
T clinical scanner, are applied to map brain metabolite signals and to estimate metabolites
T2 relaxation values. Multiple spectroscopic images from a selected tissue column through
the brain are obtained in scan time of less than 10 minutes. The potential to improve signal-
to-noise ratios by adding data from several different echoes is examined. Separate
acquisitions with the line scan RARE spectroscopic imaging methods are shown to provide
column maps of major brain metabolites in 90 seconds. Due to the inherent tradeoffs
between T2 decay, spectral resolution and echo spacing in application to the brain, separate
quantification of choline and creatine resonances is not achieved with the present
implementation. Instead, combined choline + creatine (Cho + Cr) resonance is quantified in
the brain studies, as well as the N-acetyl aspartate (NAA) resonance.
The goal of this chapter is to demonstrate the ability to make rapid line scan spatial
metabolite maps in 90 seconds or to collected data sets suitable for T2 decay analyses of
Cho+ Cr and NAA resonances in under 10 minutes, features which may prove of practical
clinical utility in the diagnosis and monitoring of brain pathologies. This chapter begins with
a review on biochemical functions of major metabolites in human brain. It is followed by
our studies on brain metabolites using the line scan CPMG and RARE techniques. The
chapter concludes with a discussion on the limitations and potential uses of the methods as
applied to the brain.
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6.1 Function of Major Metabolites in Brain
This section provides some relevant biochemical background about the major
resonance peaks observed in 1H spectroscopy. Some of the materials are from a review
paper on 1H spectroscopy by Miller [1]. The chemicals contributing to the three main peaks
are: N-acetyl-aspartate (NAA), creatine/phosphocreatine (Cr), and choline-containing
compounds (Cho). NAA is attributed to the peak seen at shift of 2.0 ppm, Cr to 3.0 ppm,
and Cho to 3.2 ppm.
Discovered in 1956, NAA is present within neurons although its biological function
is largely unknown. Studies show that NAA level changes with different diseases. For
example, NAA is 3 times higher in amyotrophic lateral sclerosis, a progressive degenerative
disease affecting motor systems in brain and spinal cord, than in normal controls. The
concentration of NAA decreases in non-neuronal tumor, such as chronic multiple sclerosis
where there is a loss of axons. However, the level of NAA is normal in acute multiple
sclerosis where there is no loss of axons. Also the excess NAA is shown partially
responsible for certain degenerative disease in early childhood such as canavan disease. It is
suggested the potential of NAA as neuronal marker to study various neuron diseases.
Creatine is from the diet and synthesized within the liver, kidney, and pancreas.
Humans have approximately 120 g of creatine and creatine phosphate present in muscle and
neurons. It serves as reserve for energy metabolism. The single peak measured at 3.0 ppm
with 1H spectroscopy consists of both creatine phosphate and creatine while 31P NMR
measures only creatine phosphate. It is suggested creatine peak be used as control value
even though studies show that the creatine peak decreases on brain tumor and infectious
brain masses.
Choline is a nutrient from most foods. Cho is associated with neurotransmitter that
is critical for memory, cognition and mood. It is also a related the cell membrane. The Cho
peak at 3.2 ppm in 1H spectroscopy consists of a complex mixture of Cho-containing
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compounds. Studies show that the Cho peak changes significantly with stroke, degenerative
dementia, drug intake, and infectious and neoplastic brain masses. For example, Cho rises
with brain ischemia and decreases with Alzheimer's disease.
The preliminary studies of in vivo 1H spectroscopy have found increased Cho and
decreased NAA and Cr peaks in tumors. 'H MR spectroscopy shows great promises for
aiding diagnosis of various brain diseases.
6.2 Studies of Brain Metabolites
6.2.1 Introduction
The detection and mapping of low concentration brain metabolites with proton MR
spectroscopy is an evolving research field with potentially important clinical applications.
Measurement of signals from choline containing compounds, total creatine, N-acetyl-
aspartate, and lactate has proven feasible at the routine clinical imaging field strength of 1.5
Tesla. Though the studies are of an inherently low signal-to-noise nature, chemical
signatures from brain metabolites obtained with proton spectroscopic studies may
ultimately prove useful in diagnosing or monitoring the effects of therapy in a number of
brain disorders such as tumors [2-6], stroke [7, 8], multiple sclerosis [9], and
neurodegenerative disorders [10-12].
Single voxel acquisitions based on the STEAM and PRESS sequences have played
important roles in determining the fundamental characteristics of proton brain spectra [13-
18]. However, dramatic increases in the extent of spatial coverage and spatial resolution can
made using chemical shift imaging principles [19] based phase encoding STEAM, PRESS
or spin echo signals [20-23]. Such techniques are becoming increasingly more common in
the study of brain disorders with proton MR spectroscopy [3, 4, 11].
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The line scan CPMG and RARE spectroscopic imaging sequences used for brain
metabolites studies are a modified version of sequences described in Chapter 3.
The water concentration in the brain is about 40 - 50 M (mole per litter) while the
concentrations of the brain metabolites are in the order of 10 mM. So the signals from
metabolites are about 5000 times smaller than that from water. Due to the limited dynamic
range the strong lipid signal from the skull, it is impossible to observe the small metabolite
peaks without water and lipid suppression using the sequences shown in Chapter 3. Figure
6.1 represents the spectroscopic image of a column across the brain without the water
suppression and lipid saturation. The huge water signal and lipid signals make the direct
observation of low concentration brain metabolites impossible.
Figure 6.1: A spectroscopic image of a column oriented across the brain from
left to right without the water suppression and lipid nulling.
Figure 6.2 shows the modified line scan CPMG sequence that is capable of
detecting the low concentration brain metabolites. The primary modifications include the
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placement of a non-selective inversion pulse as in STIR imaging technique [31] and three
chemical shift selective (CHESS) pulses [32]. The non-selective 1800 (3 ms one-side lobe
sinc) pulse placed 175 ms prior to the excitation pulse of the CPMG sequence reduces the
lipid signal from the skull. The CHESS pulses (20 ms sinc, ±75 Hz bandwidth) that are
applied between the inversion pulse and the excitation pulse of the CPMG sequence flip the
water protons 90' degree into the transverse plane. The following spoiling gradients
dephase the water protons along x, y and z directions. As the coherence of the water protons
is destroyed, the small metabolites signals can be picked up by the receivers.
90 x 90 x
F InIn
Figure 6.2: Line scan CPMG spectroscopic imaging sequence modified for brain study. A non-
selective 180 pulse nulls the skull lipid signal. Three CHESS pulses suppress the
water signal. Echoes are then collected without readout gradients. Only 2 echoes are
shown.
134
-- "AA
IA
GIL
Figure 6.3. Images from a healthy 38-year-old man. (a): Ti-weighted localizing image depicts the
15 mm thick column. (b): A 4 s scan scout image confirms the column with a dark band. The very
bright signal is a consequence of the multiplicative factor of 350 applied to the sampled data. (c-e):
CPMG spectroscopic images of first 3 echoes. TEs are 145, 290, 435 ms respectively. (f): Image of
90 seconds 3-echo RARE scan. (g): A summation image generated by adding the first 3 echoes.
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is a 4 seconds scout image (5 echo RARE, 30 phase encodes, TR of 600 ms) used to
quickly outline and confirm the position of the target tissue column with a dark saturation
band. The very bright signal from unsaturated tissue is a consequence of the muliplicative
factor of 350 applied to the sampled data for bringing up the low concentration metabolites.
Several 15 seconds RARE spectroscopic scan of the column were run to optimize water
suppression through minor adjustments of the third CHESS pulse amplitude.
Figure 6.3 (c - e) depict first 3 of 5-echo CPMG spectroscopic images of the
column with signal readout setting of 128 ms. The echo times are 145, 290, 435 ms
respectively. These images were acquired in 8 minutes and 42 seconds (8 signal averages,
30 phase encodes, 2 s TR). The absolute spectral resolution (vertical axis) is 8 Hz which is
zero filled to 4 Hz. The nominal voxel size is 1.5 x 1.5 x 1 cm 3 , or 2.25 cc and zero filling
making an apparent spatial resolution of approximately 1.2 mm along the column. The
arrows point the residual water resonance, the lipid resonance from the skull, the NAA, and
the combined Cho+Cr resonance. Note that the spectral resolution is generally not sufficient
to allow for independent quantification of the choline peak at 3.2 ppm and the total creatine
peak at 3.0 ppm. Figure 6.3 (f) is the 90 seconds 3-echo RARE spectroscopic image of the
column. The effective TE is 290 ms with echo readouts of 128 ms. Primary bands from
brain metabolites are still detectable, though considerable spatial blurring due to the T2
weighting of k-space data is observed. Note that despite the spatial blurring of lipid signal
along the column, the lipid signal never intersects with the NAA band anywhere in the
brain. Figure 6.3 (g) is a summation image from the first 3 echoes. It was generated by
adding raw data of the first 3 echoes before Fourier transformation and magnitude
reconstruction. The T2 weighting of such image is given by TE and n, as defined in the
previous section. Signal-to-noise ratio measured for NAA is an approximately 15% better
than that from the first echo spectra in Figure 6. 3 (c) (SNR = 7.7 ± 1.3 vs SNR = 6.7 +
1.5). Spectra from the RARE data at the same location (Figure 6.3 (f)) show decreased
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SNR and increased lipid bleed, a phenomenon well-known from imaging studies with
RARE [33, 34].
From the arrow location in Figure 6.3 (g), spectra averaged over four adjacent pixels
along the column (15 x 15 x 5 mm 3 nominal voxel size) are plotted in Figure 6.4 for the
first 3 echoes of the CPMG acquisition. The solid lines are the best fits to Gaussian
functions for the residual water peak, the overlapping Cho+Cr peak, and the NAA peak. In
adult volunteers studied with 5 echo CPMG sequence, the residual water peak, the NAA
peak, and the combined Cho+Cr peak were generally quantifiable with Gaussian fitting at
the first three echoes. The NAA peak generally persisted in the 4th and 5th echoes while the
Cho+Cr peak was usually in the noise level at these later echoes. Peak areas extracted from
these fits are used to estimate spectral T2 relaxation values.
Figure 6.5 presents the spectral T2 decay of the combined Cho+Cr peak area and
the NAA peak area with echo time from the volunteer study in Figure 6.3. The plot was
generated by averaging data from four 15 x 15 x 5 mm 3 voxels along the column. T2
relaxation times estimated are: 318 ms (combined Cho+Cr) and 357 ms (NAA).
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Figure 6.4: Magnitude brain spectra at the first 3 echoes of the 5-echo CPMG
acquisition in Figure 6.3. These spectra were extracted at the spatial location
pointed by the arrow in Figure 6.3 (g). Solid lines are the best fits to Gaussians.
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Figure 6.5: Spectral T2 decay of the combined Cho+Cr peak and the NAA peak
as obtained from the data set of Figure 6.3. Note that the NAA signal was
quantifiable even at the last two echoes with TEs of 580 and 725 ms respectively.
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Figure 6.6 shows a spatial profile for water and NAA peaks along the column. The
integrated water and NAA signal intensities as functions of position along the column are
plotted. The water trace was taken directly from integration of signal intensity across the
column dimension in the T1-weighted image (Figure 6.3 (a)). The locations corresponding
to the ventricles appear as dips in the water profile due to the T1 -weighting nature of this
localizing image (TR/TE = 600/12 ms). The NAA trace was taken from integration across
the NAA frequency band in the first echo spectroscopic data sets of the column (TE = 145
ms, Figure 6.3 (c)). The metabolites trace has been multiplied by a scaling factor to make it
comparable to the water trace for visualization. Both traces show coincident spikes at the
edges of the skull due to strong lipid signal in the T1 -weighted localizer and to lipid signal
bleed along the frequency direction into the NAA band at scalp locations in the TE = 145
ms spectroscopic image. Of interest is the correlation between signal drops at ventricle
locations in the T1-weighted water profiles and drops in the NAA integrated signal intensity
at the same locations, presumably due to partial volume averaging of NAA containing brain
tissue with non-NAA containing cerebrospinal fluid.
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Figure 6.6: The integrated water and NAA signal intensities as functions of position
along the column outlined in Figure 6.3 (a). The water trace was taken directly from
integration of signal intensity across the column dimension in the TI-weighted image
of Figure 6.3 (a). The NAA trace was taken from integration across the NA A frequency
band in the first echo spectroscopic image (Figure 6.3 (c)). The metabolites trace has
been multiplied by a scaling factor to make it comparable to water trace for visualization.
Good correlation is observed between the two traces with coincident dips at locations
of the ventricles and spikes at locations in the scalp.
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Figure 6.7: Line scan CPMG study of a healthy 26-year-old man with the 20 mm thick column
oriented anteriorly to posteriorly. (a): One of five localizing images acquired in 23 seconds with
a 3-echo RARE acqusition. (b): A TI-weighted 15 seconds scout image used to quickly outline
and confirm the position of the targeted tissue column with a dark saturation band. Unlike Figure 6.2,
the multiplicative factor of 350 are not applied to the sampled data. (c): First echo spectroscopic
image with TE of 114 ms. (d): The summed spectroscopic image generated by adding data from
the first 3 echoes of the CPMG acquisition.
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A total of eight healthy volunteers were studied with the 5 echo CPMG line scan to
determine metabolites T2 values. Five studies were performed with the columns aligned
from left to right as in Figure 6.3. Four of them were scanned with 128 ms readout, 145 ms
echo spacing and one with 96 ms readout, 114 ms echo spacing. Three studies were
performed with the columns oriented from anterior to posterior as in Figure 6.7, all using
the 96 ms readout and 114 ms echo spacing. The TR was 2 seconds for all 8 studies. From
each data set, 4 to 6 brain spectra were extracted from 15 x 15 x 5 mm 3 or 20 x 20 x 5
mm3 nominal voxel volumes and spectral peaks fit with Gaussian functions at every TE, as
in Figure 6. 4. Table 6.1 lists the ranges of T2 values found for the NAA signal and the
composite Cho+Cr signal. The mean and standard deviations are the results from 45
spectral T2 decay data sets. The ratio of the NAA signal to the combined Cho+Cr signal
calculated from spectral peak areas extrapolated back to zero TE is 0.95 ± 0.34.
Table 6.1: T2 values obtained from analysis of 45 spectral relaxation data sets of 8
healthy adult volunteers. T2 for the Cho/Cr peak was smaller than that for NAA peak.
Figure 6.8 is an example of the techniques as applied to a 17-year-old boy with a
brain tumor of glial origin. Shown are the 20 x 20 mm 2 tissue column selected for
interrogation from a T2-weighted localizing image (a), the summation image generated
from the first 3 echoes of a 5-echo CPMG data set (b), and the 3 echo RARE spectroscopic
image acquired only in 90 seconds (c). The scan parameters are identical to those used for
Figure 6.3. The location of the tumor, marked with an arrow in Figure 6.8 (b), clearly
shows a depletion of NAA signal and an increase in the combined Cho+Cr peak,
presumably due to increased choline in tumor cells. Note that with this spectral resolution,
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Range (ms) Mean ± SD (ms)
Cho/Cr 175- 769 286 ± 82
NAA 277- 772 435 ± 113
Figure 6.8 (a): RARE T2-weighted localizer shows the tumor and the 20 mm thick column.
(b): Summation image using data from the first 3 echoes of a 5-echo CPMG acquisition. (c):
The spectroscopic image of the 90 seconds RARE acquisition with effective TE of 290 ms.
147
Figure 6.8 (a): RARE T2-weighted localizer shows the tumor and the 20 mm thick column.
(b): Summation image using data from the first 3 echoes of a 5-echo CPMG acquisition. (c):
The spectroscopic image of the 90 seconds RARE acquisition with effective TE of 290 ms.
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Figure 6.9 (a) and (b) are plots of spectra at each echo time extracted from locations
in the tumor and from normal brain tissue on the contralateral side for the patient in Figure
6.8. The nominal voxel size is 20 x 20 x 5 mm3 . The T2 value of the composite Cho+Cr
peak in the tumor, averaged from two locations, was 303 ± 37 ms. The Cho+Cr T 2 value
for normal brain tissue, averaged from four separate 20 x 20 x 5 mm3 voxels located on the
contralatereal side was 385 ± 45 ms. A similar scan performed on this patient four month
later and with no intervening treatment yielded T2 values for Cho+Cr of 322 ± 42 ms in
the tumor and 411 ± 47 ms in normal brain tissue, consistent with results from the first
scan.
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Figure 6.9. (top): CPMG spectra of 5 TEs from a voxel located in the tumor as pointed
by the arrow in Figure 6.8 (b). Only residual water and the combined Cho+Cr signal
are apparent in the spectra. (bottom): CPMG spectra from a voxel in normal brain
tissue (contralateral side) of the tumor patient showing both Cho+Cr and NAA signals.
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Figure 6.10 presents spatial profiles for combined Cho+Cr, NAA, and water signals
for the tumor patient in Figure 6.8. The metabolites signals are integrated across the column
from the summation image of Figure 6.8 (b), and the water profile extracted from T2 -
weighted localizer of Figure 6.8 (a). The vertical scaling of the metabolites was performed
to allow a comparison with the water profile. Horizontal scaling was also performed to
account for the different FOV for the localizing image and spectroscopic image. The sharp
lipid peak provide a natural reference points for checking the horizontal scaling factor. Note
how the dip in NAA signal and the increase in the Cho+Cr signal corresponds to increased
water signal in the tumor.
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Figure 6.10: Spatial profiles of the water signal, and scaled NAA, Cho+Cr signals
along the tissue column. The water trace was extracted from T2-weighted localizer
image of Figure 6.8 (a). The vertical scaling of the metabolites was performed to
allow a comparison with the water profile. Note the correlation between the high Cho+Cr
signals and the low NAA signals with the high water intensities at the tumor locations.
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6.3 Discussion
Two dimensional proton spectroscopic studies of long T2 brain metabolites have
become well established areas of investigation, though they have not become standard tools
in clinical neuroradiological MR exams. Typically, scan time greater than 30 minutes have
been required to generate relatively low spatial resolution 2D (32 x 32 matrix size) brain
metabolites maps of one or several selected slices [4, 11, 20, 23]. Patients, technologists,
and clinicians have become more accustomed to MR examinations consisting of several
individual scans, each lasting on the order of only several minutes. It therefore becomes
investigators interest in seeing wider clinical application of brain spectroscopy to explore
methods that extract spectroscopic information within scan time generally tolerated by MR
practitioners and patients.
Within this context, it has been shown that the use of individual CPMG generated
echoes for different spatial phase encodes steps allows for 32 x 32 spatial array mapping
of brain metabolites in approximately 10 minutes [29, 30]. For some applications, the
volume coverage and spatial resolution afforded by such 2D CSI metabolites mapping
may be required. Instead of expensive hardware upgrading with echo planar capabilities
[35, 36], the 2D CSI studies with distinct phase encoding scheme for each echo are the
practical choice.
Mapping metabolites with 2D CSI methods is advantageous in that results can be
displayed in familiar image formats and overlaid with anatomically accurate standard MR
images. However, limitations of the multi-echo approach for 2D CSI brain metabolite
mapping are worth mentioning. First, the 128 ms echo readouts used to allow for the
collection of 4 echoes prior to unacceptable signal loss from T2 decay limits spectral
resolution, making the separation of Cho from Cr resonance problematic. As noted
elsewhere [29] and here, more sophisticated lineshape analyses of the 2.9 to 3.3 ppm
spectral region may help alleviate this problem, especially if signal-to-noise can be
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improved through coil development. However, to date, only 2D CSI maps of the
combined Cho+Cr resonance have been reported with rapid multi-echo approaches because
of this problem.
Another drawback of using multiple echoes for rapid scans (in 3D, 2D or 1D
formats) is that metabolites T2 decay processes manifest themselves as artifact rather than
as a potential sources of diagnostic or physiological information. Such artifacts are fairly
well understood, and presenting themselves as ringing and spatial blurring along the phase
encode direction sampled with separate echoes [34]. The T2 decay caused spatial spread of
signal is quite apparent in the 90 second RARE line scan acquisitions (Figure 6.3 (f) and
6.8 (c)). Duyn and Moonen applied T2 correction factors to the individual raw data lines
based on the assumption of a global T2 value of 400 ms to decrease the artifact [30]. Such
strategies help in the qualitative presentation of the data but do not make quantitative T 2
analyses possible. It is well-recognized that spectral peak amplitudes at a single echo time,
or this case a single effective echo time, reflect both metabolites concentrations and T2
relaxation. Since metabolites T2 information is traded off for speed when multiple echoes
are used to bring 2D CSI brain scan times into clinically acceptable ranges, definitive
statements as to the precise cause of spectral changes (concentration or T2 change) remain
elusive.
As demonstrated above, the line scan makes quantitative brain metabolite T2
analyses feasible. In applications in which the volume coverage provided by a line scan
format is acceptable, the complete data sets can be acquired in less than 10 minutes. The
major drawback encountered with the present implementation is the overlapping Cho and
Cr resonances, precluding separate T2 quantification of these peaks. Other limitations of
the metabolite T2-decay data sets acquired with the CPMG method include inherently low
signal-to-noise ratios and the sampling of only 3 to 5 data points along the T2-decay curve.
These features account for the rather wide range of metabolites T2 values reported in Table
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6.1. However, despite the limitations mentioned, our T2 measurement demonstrate quite
reasonable agreement with existing literature data on brain metabolites T2 parameters.
The NAA T 2 values of 435 ± 113 which we found (Table 6.1) by averaging 45 NAA
T2-decay data sets from 8 volunteers is in good agreement with published reports found
by others using single voxel techniques [16, 17]. The T2 value which we found for the
combined Cho+Cr of 286 ± 82 ms (Table 6.1) is intermediate to the individual spectral T2
values at 1.5 T reported by Kreis et al [17] who list a Cr T2 value of 207 ms and a Cho T2
value of 395 ms for adults. This makes it quite apparent that the T2 relaxation time
measured from single Gaussian fits to the 3.3 to 2.9 ppm spectral region reflect both Cho
and Cr resonances. It is also of interest to note that our value of 0.95 ± 0.34 for the ratio of
NAA to combined Cho+Cr, as estimated from the spectral peak area extrapolated to zero
TE, is reasonably close to the value of 0.81 for this particular metabolite ratio as extracted
from single voxel STEAM data recently compiled by Webb et al in adults [18]. The
finding suggests that in any application in which NAA/(Cho+Cr) proves to be a useful
index, the CPMG line scan spectroscopic techniques can provide reasonable estimate of
this quantity.
A potential application for the line scan CPMG techniques as currently
implemented is in the characterization of brain tumors (Figure 6.8). In particular, long TE
spectroscopic findings in tumor to date have generally reported diminished NAA and Cr
resonances and an increased Cho peak [2-6]. Thus, our T2 measurement from the peak in
the 3.0 to 3.3 ppm spectral region in tumor most probably reflects primarily Cho peak with
little contamination from the Cr. Using single voxel approaches, several investigators have
measured metabolites T 2 values in tumors and surrounding tissue. Manton et al measured
increases in Cho T 2 values in meningiomas compared with normal brain tissue [37] and
suggested that their result may due to a difference in the relative proportion of
glycerophosphocholine to phosphocholine, the two major compounds contributing to the in
vivo Cho peak [38]. Usenius et al also reported increased Cho T2 values in several tumor
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types [39] while Kamada et al reported T 2 shortening of Cho resonances and other
metabolites peaks in peritumoral edema of several patients, including two meningioma
cases [40]. In the single tumor case we have examined with the line scan CPMG technique,
the Cho T 2 appeared shorter than the Cho+Cr T2 in normal brain tissue, consistently in
two separate exams. We speculate that calcium deposition may play some role in the T 2
shortening observed but hasten to add that many more studies are required before definitive
conclusions can be drawn as to the mechanisms affecting metabolite T2 values in tumor.
The line scan approach is appealing in this regard since a single relatively brief scan yields
data sets from which such information can be extracted from both normal and pathological
tissue.
The final application considered with multiple echo CPMG type acquisitions is the
addition of echoes for improving signal-to-noise. Since noise in different echoes is
uncorrelated, a gain in signal-to-noise may be anticipated when echoes are added to form
summation data sets like those shown in Figure 6.3 (g). However, T2-decay also plays a
role, diminishing the signal-to-noise gains obtained by adding successive echoes. For the
NAA peak of the cases in Figure 6.3 (g), only a modest gain in signal-to-noise of
approximately 15% was obtained when raw data from the first 3 echoes at 145, 290, 435
ms were added. This result suggests that echo addition does not present a major advantage
of CPMG spectroscopic imaging scans in brain.
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Chapter 7
Conclusion and Future Topics
This thesis has presented innovative proton magnetic resonance spectroscopic
imaging techniques and their clinical applications in vivo. This chapter summarizes the
thesis and suggests some of the potential clinical applications. In addition, the modification
of current techniques and future topics for research that are relevant to this thesis are
discussed.
7.1 Conclusion
This thesis and its contributions to the field of magnetic resonance spectroscopic
imaging are summarized as follows:
* This thesis has developed and implemented innovative magnetic resonance
spectroscopic imaging methodologies. The methods are based on spectroscopic
interrogation of voxels along strategically oriented tissue columns which can be selected on-
line. The techniques combine some of the most attractive features of both imaging and
spectroscopy methods utilizing Carr-Purcell-Meiboom-Gill multiple-echo sequence, rapid
acquisition and relaxation enhanced or equivalently fast spin echo sequence, inner-volume
localization, and chemical shift imaging principles. The techniques offer a compromise
between the low-spectral-resolution, high-spatial-resolution, large-volume-coverage
imaging methods of Dixon and Sepponen and the high-spectral-resolution, single-voxel
localized proton spectroscopy approaches. Spectroscopic images with high spatial, variable
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spectral resolution and adequate volume coverage are generated in clinically useful time
periods of 10 minutes or less.
* The techniques can be performed either in imaging mode or in spectroscopy mode.
In imaging mode, localizing images with a saturated dark band representing the selected
tissue column are generated with the standard RARE sequence. In spectroscopy mode,
spectroscopic images of the column are created with either the CPMG or the RARE
sequence. The CPMG spectroscopic imaging techniques allow spectral quantitation
(concentration and T2) from eight separate TEs in each voxel along the tissue column. The
RARE spectroscopic imaging techniques provide rapid mapping of proton spectral
resonances and estimation of spectral T1 relaxation time.
* The spectroscopic imaging techniques developed in this thesis are fast ad non-
invasive in the clinical setting. The techniques generate spectroscopic images much faster
than conventional MR spectroscopic techniques while the images are still informative. As
current implemented, the CPMG spectroscopic imaging techniques generated images that
suitable for spectral T2 and concentration analysis in 4 minutes and 18 seconds while
conventional spectroscopic techniques need scan time of 40 minutes. The RARE
spectroscopic imaging techniques with 7 echo train generate image in 36 seconds versus 4.5
minutes for the conventional spectroscopic techniques. Because of the short scan time, the
techniques developed in this thesis are tolerated by patients and MR practitioner. Also they
make practical spectroscopic studies (such as on very ill patients or on children) feasible.
* The new methodologies are developed and implemented on a conventional 1.5 Tesla
clinical MRI scanner with standard software and hardware configurations. Therefore, it is
convenient to extract spectroscopic information along with conventional MRI examinations.
The practical significance of the technologies is that they can be feasibly incorporated into
clinical protocols to perform spectroscopic studies on clinically important targets.
* The techniques provides the optimization between acquisition speed, spectral
resolution, minimum echo time, and T2 measurement. The spectroscopic images can be
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acquired with different spectral resolution. The variable spectral readouts and the
corresponding minimum echo spacing, as well as the echo train length, can be chosen on-
line for different applications. The long sampling time yields images with high spectral
resolution, and prolongs the echo spacing. As a result, the amount of unavoidable T2 decay
increases in the multiple echo train. On the other hand, the small echo spacing decreases the
T2 decay and increases the signal to noise ratio, so more echoes per TR can be obtained in
the multiple echo train acquisitions. The CPMG spectroscopic imaging sequence trades
spectral resolution for spectral T2 measurement while the RARE spectroscopic imaging
technique sacrifices spectral T2 measurement for acquisition speed.
* The spectroscopic imaging techniques are demonstrated in vivo. Spectral
concentrations, T1 and T2 relaxation values are obtained for bone marrow and brain
metabolites. Specifically, quantitation of water and saturated fat, or cellularity measurement,
is performed on vertebral marrow of a group healthy adult volunteers. Studies of
developing bone marrow in knee are performed on a group of children and a group of adult
volunteers. Furthermore, with variable spectral resolution and an added non-selective
inversion pulse before the excitation, the techniques are shown applicable in quantifying the
lipid chemical composition. The demonstrations also include lipid spectral T1 relaxation
measurements, terminal methyl proton detection even at limited spectral resolution,
mapping of fat unsaturation, and study of levels of mono-unsaturated versus poly-
unsaturated triglycerides. In addition, the techniques are modified with three CHESS pulses
to suppress water, and applied to quantify and map human brain metabolites. The clinical
feasibility of brain metabolites studies is illustrated from a group of healthy adult volunteers
and a tumor patient.
* The thesis designed an automated image analysis software package. The image
processing software, designed in graphics user interface format on Sun workstation, makes
it convenient to extract spectroscopic information from acquired spectroscopic images.
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* The fast techniques demonstrated in this thesis may provide opportunities to
perform dynamic chemical shift imaging studies in vivo. Like functional MRI where many
fast imaging techniques have been developed, the fast scan spectroscopic imaging
techniques are also essential in dynamic chemical shift studies. In contrast to echo-planar
imaging that requires specialized and expensive hardware for fast gradient switching, large
peak amplitudes and fast data acquisition, the new MR spectroscopic imaging techniques
require no special hardware and software since they are developed on conventional scanner
with standard configuration.
7.2 Potential Applications
The new methodologies has been demonstrated applicable in many possible
applications, such as spectral quantitation of bone marrow in vertebral and knee, metabolites
mapping in human brain. Also the feasibility to study the lipid chemical composition and
degree of triglycerides in fatty acids are presented.
The techniques developed in this thesis promise many possible applications in vivo.
One is to quantitate lipid spectra in bone marrow during and after radiation therapy and
chemotherapy for patients with bone marrow diseases like leukemia. Another one is to
study the evolution of cerebral metabolites within brain tumors to see how relative
concentrations of MR observable metabolites correlate with the state of the tumors and the
relative progress of various therapies. The other application is to study fat metabolites
disorders, such as cystic fibrosis.
7.3 Future Topics for Research
7.3.1 Lipid Enhancement
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One future work that is relevant to this thesis is to boost the small lipid resonance
peaks other than methylene peak by modifying the line scan CPMG spectroscopic imaging
techniques. As presented in thesis, the small lipid peaks contain information about lipid
chemical structure, such as fatty acid chain length, degree of mono-unsaturation and poly-
unsaturation.
The problem encountered in performing conventional spin echo technique to study
the small lipid resonance protons is the low signal-to-noise ratio. To enhance these small
lipid resonance signals, we propose that the line scan CPMG spectroscopic techniques be
further modified. Instead of sampling each echo after every 1800 pulse in a CPMG echo
train, only the positive half of the last echo is sampled. The volume localization is still a
column. The new CPMG pulse sequence is like: r / 2 (+x), r, 7r (+y), 2T, 7r (+y), 2'r,
..., r (+y), t, positive-half-echo-readout. The TE of the spectroscopic image is n(2t),
where n is the number of echo per TR. The reason of acquiring only the positive half echo
is to make TE independent of sampling time when variable spectral readout filters are used.
Another reason is that the TE is shortened so that the small T2 species can be observed.
To demonstrate the lipid enhancement over the conventional spin echo technique,
we have modified the line scan CPMG spectroscopic imaging sequence as described above
and applied it on a bottle of fish oil. For comparison, a spin echo sequence that is modified
with volume localization being a column is also used to sample spectral information
without readout gradient from the same fish oil bottle. The TEs used for both sequences
are the same. The location of the column in the spin echo sequence is the same as in the
modified line scan CPMG spectroscopic sequence. As in the CPMG acquisition, only the
positive half echo is sampled in the spin echo sequence. Therefore, the only difference
between these two sequences are the multiple selective refocusing 1800 pulses used in the
CPMG sequence.
Our initial study has observed the lipid enhancement by the modified CPMG
spectroscopic imaging sequence over the spin echo sequence. The olefinic proton peak is
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enhanced about 100% in CPMG acquisition. The lipid enhancement may result from the
elimination of diffusion-mediated susceptibility dephasing and the suppression of J-
coupling modulation from multiple refocusing pulses train as shown by Henkelman [1].
Further in vitro and in vivo studies are needed to prove the applicability of such proposal.
7.3.2 Diffusion Spectroscopic Imaging
Another future work that is relevant to this thesis is to study diffusion properties of
brain metabolites by extending the line scan CPMG spectroscopic imaging techniques. The
rationale is that in vivo diffusion coefficients measurement contains information about
cellular parameters such as dimensionality, compartmentation, and transport processes.
Previous clinical applications include determination of white matter fiber orientation in the
central nervous system, and evaluation of brain infarctions at very early stage when
findings of other modalities, including T, - and T2 -weighted MR image are still normal
[2].
We propose that the line scan CPMG spectroscopic techniques be modified either
to acquire diffusion weighted spectroscopic images or to measure the diffusion coefficients
of the low concentration brain metabolites. Specifically, three bi-polar diffusion gradients,
each in one direction (x, y, and z), can be added between excitation 900 pulse and the first
refocusing 1800 pulse. The duration of the diffusion gradients is arranged not to increase
the echo spacing as the full echo after every refocusing pulse is sampled. So the modified
li:ne scan CPMG spectroscopic acquisition will generated images at different TEs that
contain both spectral T2 and diffusion information. By varying the amplitude of the
diffusion gradients, the spectral diffusion coefficients for brain metabolites can be
measured.
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